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Both DNA and RNA can fold into a variety of non-canonical structures. Non-canonical 
structures, such as triplexes and G-quadruplexes, are an active research area due to their 
biological significance and therapeutic potential. As structural complexity and 
conformational transitions are essential for the diverse biological roles of nucleic acids, 
characterization of the dynamic nature of nucleic acid is vital to understand their 
functional properties. This thesis focuses on 19F NMR spectroscopy as a tool that can be 
used to investigate the conformational polymorphism of nucleic acids and the dynamic 
nature of nucleic acid-ligand interactions.  The utility of 19F NMR is based on covalently 
incorporated fluorine labels that act sensitive reporters upon conformational transition.  
In this study, six novel fluorine-labelled building blocks were synthesized and 
incorporated into oligonucleotides applying standard solid-phase oligonucleotide 
synthesis. The building blocks were successfully used to investigate DNA and RNA 
triplexes, RNA invasion and bistable hairpin-G-quadruplex RNA structures. Melting of 
triplexes could be followed from well-distinguish 19F signals of the triplex, duplex and 
single strand species, and melting temperatures of the structures were obtained. The 
temperature dependent 19F NMR data of the bistable RNAs enabled to characterize 
melting processes, melting temperatures and thermodynamic parameters. In addition, 
ion induced changes at the hairpin-G-quadruplex equilibrium positions were 
successfully monitored. In general, the 19F NMR experiments provided new information 
on investigated structures and demonstrated that five of the building blocks can be 
considered suitable for further 19F NMR applications. 
 
 






Kemian laitos/Luonnontieteiden ja tekniikan tiedekunta 
 
GRANQVIST, LOTTA: Uusia 19F NMR sensoreita DNA:n ja RNA:n korkeamman 
asteen sekundaarirakenteiden karakterisointiin 
 
Väitöskirja, 156 s. 




DNA ja RNA voivat laskostua erilaisiksi ei-kanonisiksi rakenteiksi. Ei-kanoniset 
rakenteet, kuten kolmoiskierteet ja G-kvadrupleksit, ovat aktiivinen tutkimusalue niiden 
biologisen merkittävyyden ja niihin liittyvien terapeuttisten mahdollisuuksien takia. 
Koska rakenteellinen monimutkaisuus ja konformaatiomuutokset ovat välttämättömiä 
nukleliinihappojen biologisille toiminnalle, rakenteiden ja niiden dynamiikan 
karakterisointi on tärkeäää toiminnallisten ominaisuuksien ymmärtämiselle. Tässä 
väitöskirjassa keskityttiin 19F NMR spektroskopiaan tutkimusmenetelmänä, jolla 
voidaan tutkia nukleiinihappojen konformationaalista monimuotoisuuutta ja 
nukleiinihappojen ja niiden ligandien välisiä vuorovaikutuksia. 19F NMR perustuu 
nukleiinihappoihin kovalenttisesti liitettyihin fluorileimoihin, jotka toimivat herkkinä 
reporttereina konformaatiomuutosta detektoitaessa.  
Tutkimuksessa syntetisoitiin kuusi fluorileimatttua rakennusyksikköä, jotka liitettiin 
oligonukleotideihin käyttämällä vakiintunutta kiintokantajalla tapahtuvaa 
oligonukleotidien synteesimenetelmää. Rakenneyksiköillä tutkittiin onnistuneesti DNA 
ja RNA kolmoiskierteitä, RNA:n invaasiota ja kahtaispysyviä hiusneula-G-kvadrupleksi 
RNA rakenteita. Kolmoiskierteiden denaturaatiota pystyttiin seuraamaan 
yksityiskohtaisesti hyvin erottuvista kolmoiskierrettä, kaksoiskierrettä ja yksinauhaista 
rakennetta vastaavista fluorisignaaleista. Kahtaispysyvien rakenteiden 
lämpötilariippuvainen käyttäytyminen pystyttiin karakterisoimaan, mikä mahdollisti 
sulamislämpötilojen ja termodynaamisten arvojen määrittämisen. Tämän lisäksi ionien 
vaikutusta hiusneula-G-kvadrupleksi tasapainotiloihin havannoitiin onnistuneesti. 
Yleisesti 19F NMR tutkimuksilla saatiin uutta tietoa tutkituista rakenteista. Lisäksi 
tutkimukset osoittivat että viiden syntetisoidun rakennusyksikön ominaisuudet 
soveltunevat myös muihin 19F NMR tutkimuksiin.   
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1. INTRODUCTION 
Fluorine-19 nuclear magnetic resonance (19F NMR) spectroscopy has numerous 
applications in chemical biology.1-12 The high detection sensitivity of fluorine combined 
with the intrinsic sensitivity of fluorine chemical shifts to the local environment has led 
to many successful 19F NMR applications also for investigation of biological 
macromolecules.1-6,8,9,11,12 Fluorine is an unnatural element in macromolecules that is 
essentially absent from biological systems. Therefore, an obvious prerequisite for 19F 
NMR spectroscopy is the incorporation of fluorine into investigated molecules. 
However, the lack of interfering background signals provides a great advantage in NMR 
spectroscopy. 19F NMR spectroscopy was recognized as a potential method to 
investigate biologically important macromolecules over 40 years ago.13,14 Employing 
fluorine as a spin label to investigate macromolecules by introducing it either into the 
macromolecule13 or into its ligand14 was first established with proteins, and this concept 
was embraced a few years later in the nucleic acid field. In 1977, two independent studies 
reported the potential of the fluorine labelling approach for 19F NMR studies of nucleic 
acids.15,16 Marshall and Smith reported their 19F NMR studies on fluorine-labelled 5S 
ribosomal RNA (rRNA)15, and Horowitz and co-workers published their research on 
fluorine-labelled transfer RNA (tRNA)16. Since then, 19F NMR has been used to 
investigate several artificial and biologically important nucleic acid structures, such as 
aptamers17-19, viral regulatory hairpins20-25, riboswitches26-29, ribozymes30-32, DNA 
adducts33,34, triplexes35,36 and telomeric G-quadruplexes37-40. 
Technical and synthetic advances have played and are still playing a significant role in 
the progress of 19F NMR spectroscopy applications. Substantial advances have been 
made in NMR instrumentation that increase feasibility and sensitivity of 19F 
detection.4,5,8 Recent advances in the hyperpolarized NMR technique (HP NMR) have 
greatly enhanced the sensitivity of 19F detection, and HP 19F NMR is expected to 
contribute generally to future macromolecule research.41,42 Significant progress in 
synthetic fluorine chemistry has provided straightforward access to numerous fluorine 
containing macromolecules and small molecules.6,12,43-45 In addition, advances in 
oligonucleotide synthesis techniques have played a crucial role in nucleic acid-related 
research in general.46-51 
Progress in the nucleic acid field has been slower than in the protein field, but interest in 
nucleic acid-related 19F NMR research has dramatically increased in recent years. The 
structural and functional diversity of nucleic acids have increased tremendously and this 
progress has also impacted 19F NMR research. In addition, the 19F NMR spectroscopy-
based techniques employed in drug development have started to shift from the protein 
field to the nucleic acid field.17,40,52 Moreover, 19F NMR spectroscopy based methods 
that utilize fluorinated oligonucleotides as hybridization probes53-58 have recently been 
developed and have also received interest in magnetic resonance imaging (MRI)53,54,57. 
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The growing knowledge of nucleic acids provides limitless research opportunities, and 
considering instrumental and synthetic developments as well as the variety of potential 
applications, 19F NMR spectroscopy may become a routine detection method in nucleic 
acids research. 
1.1 19F NMR and nucleic acids 
Fluorine-19 has several advantageous NMR properties: it has a spin of ½, a high 
gyromagnetic ratio, and it has a natural abundance of 100%.2,59,60 19F sensitivity is high, 
83% of the sensitivity of 1H, and much higher than that of 13C, 15N and 31P (Table 1). 19F 
has a wide chemical shift range (over 400 ppm), and 19F shifts are highly sensitive to 
changes in the local environment. In addition, 19F is absent from nucleic acids and the 
background signal interference is thus negligible with typical NMR measurement 
conditions. The disadvantage of 19F NMR spectroscopy is that the 19F reporter group 
(label, probe) must be incorporated into nucleic acids or into nucleic acid ligands.1,2,5,8,12 
Because an introduced modification may significantly alter the native properties of 
nucleic acids, the influence of the fluorine substitution should be carefully evaluated. 
The chemical and physical properties of fluorine, however, are highly beneficial for 
modulating pharmacological properties of small molecular ligands.44 
 
Much of the interest in 19F NMR spectroscopy arises from the simplicity and 
informational richness of one-dimensional (1D) 19F NMR spectra.1,2,4-6,8,9,12 In particular, 
the strength of 19F NMR is its ability to provide insight into the complex nature of the 
dynamic intra- and intermolecular structural equilibria of nucleic acids and dynamic 
behaviour of nucleic acid-ligand complexes.1,2,5,8,12 In addition to solution-state NMR, 
solid-state 19F NMR methods have been used to investigate nucleic acids.22,61-65 A 
common problem with 1H NMR studies on large molecules is the abundance of protons 
that need to be assigned and the severe signal overlap due to the narrow chemical shift 
range (10-15 ppm) of protons.66-72 Introducing a spin label such as 19F into the nucleic 
Table 1.2,60 NMR properties of selected nucleus  
Nucleus Spin (I) 
Gyromagnetic 
ratio 




1H ½ 26.7519 99.98 1.0 
19F ½ 25.181 100 0.83 
13C ½ 6.7283 1.108 0.0159 
15N ½ -2.712 0.37 0.00134 
31P ½ 10.841 100 0.066 
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acid may hence provide clear advantages.1,2,5,8,72 Compared to spectrophotometric 
methods commonly used to investigate nucleic acids such as ultraviolet spectroscopy 
(UV)73-75, circular dichroism (CD)76-78, and fluorescence79,80, NMR methods are 
inherently less sensitive. However, as with other NMR nuclei 19F NMR spectroscopy 
has other advantageous properties, such as its ability to provide more detailed 
information at local levels and information on coexisting structures.2,5,8,12 19F NMR is 
often used in conjunction with other methods, and it is considered an independent 
complementary method rather than a competitive alternative to NMR with traditional 
nuclei or other methods.  
Although this thesis is focused on 1D 19F NMR applications, multidimensional homo- 
and heteronuclear NMR experiments, such as 19F/19F NOESY (nuclear Overhauser effect 
spectroscopy) and 19F/1H HOESY (heteronuclear Overhauser effect spectroscopy), have 
been used to obtain further information on nucleic acids structures.21,23,25,81-85. In 
addition, multidimensional NMR methods are central techniques for 19F signal 
assignment21,23,25,29,83, and fluorine can be used as a tool to aid the assignment of 1H 
signals84-86. 
1D 19F NMR applications for nucleic acids are mainly derived from the intrinsic 
sensitivity of the fluorine chemical shift to the local environment.2,60 In general, fluorine 
can be introduced either into a nucleic acid (nucleic acid observed, internal probes) or 
its ligand (ligand observed, external probes). Due to the high environmental sensitivity 
of fluorine, 19F signals are expected to reflect distinct state of a process of interest, such 
as conformational states or ligand-bound and unbound states (Figure 1a). Depending on 
the exchange rate of the process, three basic exchange regimes can be identified: fast 
(with well-behaving coalescence signal), intermediate or slow exchange (Figure 
1b).11,87,88 When the exchange rate is slow on the NMR timescale, two distinct signals 
are observed corresponding to individual states (free and bound or distinct 
conformations A and B). The relative peak areas of the resolved signals directly reflect 
the distribution of the states (i.e., molar fractions), and thus the integration of the signals 
allows a quantitation of the states. In the fast exchange regime, a single signal is detected 
as a weighted average signal of both states. In the case of an intermediate exchange 
process, a broad signal is detected. Depending on the goals, 19F NMR data can be used 
to obtain quantitative or qualitative information. Commonly, the interest has been in 
detecting structural equilibria or complex formation.1,2,5,8,12 In addition, 19F NMR data 
have been used to extract different parameters, such as dissociation constants 
(Kd)17,20,24,25,38,52,89, pKa values90-92, melting temperatures (Tm)19,24,36-39,55,89,93-95 and 
thermodynamic19,31,37,90,96 and kinetic30,32,96,97 parameters.  
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Figure 1. (a) A schematic presentation of internal and external fluorine probes and (b) the 
chemical exchange rates. 
The structural and conformational analysis and ligand-nucleic acid interactions studies 
have mainly utilized internal fluorine probes. Consequently, a large portion of literature 
review is focused on internal fluorine probes (Section 1.2). Using external small 
molecule fluorine probes as structural probes has been demonstrated as an alternative 
approach to internal fluorine probes, and this concept is presented in Section 1.3. Section 
1.4 is a brief summary of small molecule-nucleic acid interactions studies. 
1.2 Internal fluorine probes 
1.2.1 General properties of fluorine labels and synthesis of fluorine-
labelled oligonucleotides 
Fluorine labels can be incorporated into oligonucleotides either enzymatically or by 
chemical synthesis. Although standard oligonucleotide synthetic techniques48,69,98 may 
be applied, challenges in the synthesis of appropriate fluorine-containing building blocks 
or their poor incorporation efficiency into oligonucleotides can significantly limit the 
use of the label. The most common synthetic method is the standard solid-phase 
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This method requires that a fluorine-containing nucleoside phosphoramidite is 
compatible with automated solid-phase synthesis, including the synthesis cycle and 
cleavage conditions. An enzymatic synthesis of fluorine-labelled oligonucleotides 
requires a triphosphate analogue of a fluorine-containing nucleoside.21,23,29,91,99-101 The 
triphosphates are usually incorporated into RNA by in vitro transcription using T7 RNA 
polymerase21,23,29,91,99 or into DNA using DNA polymerase100,101. In contrast to solid-
phase synthesis, which allows the site-specific incorporation of a fluorine label, 
enzymatic synthesis typically produces a uniformly fluorine-labelled 
oligonucleotide.21,23,48,98,99 In general, enzymatic synthesis allows synthesis of larger 
oligonucleotides compared with chemical synthesis. 
In fluorinated nucleoside analogues, the fluorine moiety can be incorporated either in 
the base or the sugar.12 In addition, a few non-nucleosidic fluorine modifications have 
been attached to the 5´-end of oligonucleotides.18,37,53,102 Some of the analogues are well-
known from other applications. For example, 5-fluorouridine is a nucleoside analogue 
of the anticancer drug 5-fluorouracil103, 2´-deoxy-5-trifluoromethyluridine (trifluridine) 
is an antiviral drug104, and 2´-deoxy-2´-fluoronucleosides are known modifications in 
the antisense applications105. However, there has been growing interest in the 
development of novel fluorinated derivatives that are specifically designed for 19F NMR 
applications. The goal of development has been to improve the sensitivity and 
practicality of 19F NMR measurements.18,19,37,39,53,55,58,101,106,107 A direct approach to 
improve sensitivity is to increase the amount of magnetically equivalent fluorine atoms 
and to introduce fluorine atoms in an isolated spin system. The measurements may then 
be performed at micromolar RNA concentrations without plausibly interfering 19F-1H 
couplings (if the proton-fluorine decoupling technique is not available). In addition to 
generally improving 19F NMR spectroscopic properties, derivatives have been developed 
for more specific purposes. For example, dual probes bearing both a 19F- and a 
fluorescence-detecting moiety have been described.39,100 An important aspect for the 
development of fluorinated derivatives, however, is their effect on the native structure 
of the nucleic acid. In general, fluorine modification should not cause secondary 
structural perturbations or affect the stability of the structure. Although a non-invasive 
modification is typically highly preferable, in some applications, for example in the case 
of hybridization probes53,55,56,58, the role of perturbations is less important. The following 
chapters (1.2.1.1–1.2.1.3) describe fluorinated nucleoside and non-nucleoside 
derivatives covering some general issues, but the utility of the labelled derivative 
depends on the application.  
1.2.1.1 Base modifications 
The most common site for fluorine modification is the C5 position of pyrimidines 
(Figure 2). Substituents in the C5 position are oriented the major groove in the double 
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helix.108 Large substituents at this position are generally well tolerated and do not 
significantly disturb the structure or stability of the duplex. Sterically demanding groups 
accommodated in the major groove may, as expected, significantly affect groove-
mediated interactions.  
 
Figure 2. Structures of C5-substituted pyrimidines. 
5-Fluoropyrimidines (i.e., 5-fluorouridine15,16,20,23,25,26,28,30,64,65,83,90,97,109-111, 2´-deoxy-
5-fluorouridine35,109,111-117, 5-fluorocytidine23,25,27,28,31,32,83,111 and 2´-deoxy-
5-fluorocytidine111,116,118) have been extensively used in 19F NMR studies. 
5-Fluoropyrimidine-modified nucleic acids may be synthesized by solid-phase synthesis 
using 5-fluoropyrimidinenucleoside phosphoramidites.111,119 In addition, 
5-fluoropyrimidine (both U and C) -substituted RNAs can be produced efficiently by 
enzymatic methods.23,99 The impact of 5-fluoro modification on nucleic acid structures 
has been thoroughly investigated by several methods showing that this modification has 
20  Introduction 
 
a negligible effect on their structure or stability.23,83,92,111,120-124 Fluorine is sterically 
comparable to hydrogen, but due to its high electronegativity125, it decreases the apparent 
pKa values of cytidine N3 from 4.2 to 2.3126 and that of uridine from 9.2 to 7.623,127. These 
decreased pKa values have no observed effects on base pairing at a physiological 
pH.23,83,92,111,120-124 Fluorine substitution, however, increases the opening rates of the 
canonical Watson-Crick 5-fluoropyrimidine-adenine base pairs within the DNA or RNA 
duplex. In contrast, the opening rates are unchanged with canonical 5-fluorocytosine-
guanine base pairs. Overall, 5-fluoro pyrimidine modification has proven to be sensitive 
non-invasive label. From the 19F NMR perspective, measurements have been conducted 
either with or without proton decoupling techniques. 
2´-Deoxy-5-trifluoromethyluridine bears three magnetically equivalent fluorine atoms 
in an isolated spin system.128 The trifluoromethyl group is, however, readily converted 
to a cyano group in concentrated ammonia, which prevents the incorporation of this 
nucleoside derivative into oligonucleotides by the standard solid-phase oligonucleotide 
synthesis.129 Although this problem can be circumvented by applying milder cleavage 
conditions56,129, the modest stability of the 5-trifluoromethyl group may be reason why 
few 19F NMR experiments employ this nucleoside analogue55,56,63,128,130. (An enzymatic 
synthetic method has also been described.131,132) A 5-trifluoromethyluracil-adenine base 
pair within a DNA duplex is slightly destabilizing (compared to T-A), but the duplex 
forms a B-type duplex.128,129,133 Recently, a 2´-deoxy-5-trifluoromethylcytidine was 
incorporated into DNA by solid-phase synthesis and was demonstrated to be a sensitive 
analogue for 19F NMR studies.130 
5-[4,4,4-Trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-2´-deoxyuridine bears nine 
magnetically equivalent fluorine atoms in an isolated spin system.106 This nucleoside has 
been introduced into oligonucleotides in place of thymidine106 or uridine24,89 by solid-
phase oligonucleotide synthesis, and it has been reported to be slightly destabilizing. 
Other sterically demanding analogues contain a 3,5-bis(trifluoromethyl)phenyl group.55 
This is a sensitive reporter group containing six magnetically equivalent fluorine atoms 
that are not coupled to protons. In contrast to other fluorinated nucleoside analogues, the 
fluorine moieties of 3,5-bis(trifluoromethyl)phenyl-modified 2´-deoxyuridine analogues 
have been introduced into DNA postsynthetically (i.e., 3,5-bis(trifluoromethyl)benzoic 
acid and 4-[3,5-bis(trifluoromethyl)benzamido]benzoic acid were coupled to 
5-(3-aminopropyn-1-yl)-2´-deoxyuridine residue after solid-phase synthesis). These 
3,5-bis(trifluoromethyl)phenyl-modified analogues do not substantially effect the 
stability of the DNA duplexes; the duplexes maintain a B-type conformation, but 
deviations from the native secondary structures can be detected. 
5-[4´´-(5´´´-Aminobenzo[d]oxazol-2´´´-yl)-2´´-fluorophenyl]-2´-deoxyuridine is an 
example of a dual probe, but its utility has mainly been in fluorescence detection.100 
Recently, the applicability of a 5-[(3,5-bis(trifluoromethyl)phenyl)ethynyl]-
2´-deoxyuridine was demonstrated.19 In contrast to the 3,5-bis(trifluoromethyl)phenyl 
group bearing 2´-deoxyuridine analogues discussed above, it has been incorporated into 
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DNA as a phosphoramidite. In addition, an enzymatically incorporated 
4-(trifluoroacetyl)phenyl-modified 2´-deoxyuridine and 2´-deoxycytidine were recently 
presented as novel derivatives for 19F NMR studies.101 
In addition to fluorinated natural pyrimidine nucleobases, the well-known nonpolar 
pyrimidine isosteres 2,4-difluorotoluene and 2,4-difluorobenzene nucleoside analogues 
have been employed in a few 19F NMR studies (Figure 3).84,85,93,134 In these studies, the 
nucleoside analogues have been incorporated into oligonucleotides as corresponding 
nucleoside phosphoramidites. The fluorine atoms are magnetically non-equivalent and 
coupled to protons. Because these isosteres have been extensively used as base mimics, 
their properties have been thoroughly investigated.135-137 The shape of a 
2,4-difluorotoluene/2,4-difluorobenzene-adenine base pair closely resembles the natural 
thymine/uracil-adenine Watson-Crick base pair, but there are no hydrogen bonding 
interactions. Therefore, the 2,4-difluorotoluene/2,4-difluorobenzene substitution is 
typically structurally non-perturbing, but it decreases the stability of the double helix.  
 
Figure 3. Structures of pyrimidine isosteres and 2-fluoroadenosine. 
In contrast to fluorine-modified pyrimidine bases, the availability of fluorine-modified 
purine bases is limited, presumably due to the modest stability of these molecules.138-140 
Currently, only 2-fluoroadenosine has been employed more generally in 19F NMR 
studies (Figure 3).21,25,29,91 2-Fluoroadenosine-5´-triphosphates can be incorporated 
efficiently into RNA by enzymatic methods.21,25,29 The fluorine substituent is unstable in 
chemical RNA synthesis139,140, and thus the utility of 2-fluoroadenosine has been limited 
to uniformly substituted enzymatically produced RNAs21,25,29. Studies on uniformly 
substituted RNAs have shown that 2-fluoroadenosine is a sensitive non-invasive 
analogue for 19F NMR studies.21,25,29 The fluorine is oriented into the minor groove. 
When introduced in a double-helical RNA, 2-fluoroadenine forms a stable base pair with 
uracil and mild destabilizing perturbations observed in local base pair stabilities are 
compensated by favourable base stacking interaction. In addition to 2-fluoroadenosine, 
some other purine analogues, including 7-fluoro-7-deaza-2´-deoxyadenosine140, 
7-fluoro-7-deaza-2´-deoxyguanosine140, 2-fluoro-7-deazaadenosine91, 7-fluoro-
7-deazaadenosine91, 6-trifluoromethylpurine ribonucleoside141, and fluorinated biaryl100 
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and 4-(trifluoroacetyl)phenyl-modified101 7-deazapurine 2´-deoxynucleosides, have 
been proposed as potential derivatives for 19F NMR studies. 
Figure 4 presents more specialized fluorine-labelled nucleoside analogues, and these 
analogues are compatible with standard solid-phase synthesis. Fluorinated 2´-deoxy-
N4-(6-aminopyridin-2-yl)cytidine derivatives have been designed to interact with duplex 
DNA via Hoogsteen hydrogen bonding and have been employed to investigate triple-
helical DNA structures.58 8-[(3,5-Bis(trifluoromethyl)phenyl)ethynyl]-2´-deoxy-
guanosine is a dual probe, and it has been developed for the detection of 
G-quadruplexes.39 Due to the 3,5-bis(trifluoromethyl)phenyl group at the 8-position, 
guanine favours a syn orientation, which is favourable in the G-quadruplexes that have 
been investigated by this analogue. In addition, fluorinated arylamine guanosine DNA 
adducts33,34 have been exploited in 19F NMR studies, and these are presented in Section 
1.2.2.10. 
 
Figure 4. Structures of fluorinated nucleoside derivatives designed for specific nucleic acid 
structures. 
1.2.1.2 Sugar modifications 
Few studies have utilized sugar-modified nucleoside analogues and only two sugar 
modifications have been employed. One modification is a 2´-deoxy-2´-fluoro 
(2´-F)17,22,61,82,142, and the other is a 2´deoxy-2´-trifluoromethylthio (2´-SCF3) 
modification, which has been designed for 19F NMR applications94,107,143 (Figure 5a). 
Recently, 2´-fluoro-2´-deoxyarabinocytidine was proposed as a possible analogue for 
monitoring small molecule-DNA i-motif interactions.144 One advantage of 2´-F and 
2´-SCF3 modifications is that the label can be incorporated into any position in the 
RNA.94,107,142,143 Modifications in the sugar part, however, affect conformational 
properties and may cause significant alterations in the structure and stability of nucleic 
acids.82,94,107,143,145 In addition, plausible 2´-hydroxyl group-mediated interactions are 
disrupted. 
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Figure 5. (a) Sugar-modified nucleoside analogues. Base (B) is adenine (Ade), uracil (Ura), 
cytosine (Cyt) or guanine (Gua). (b) C3´-endo (N-type, A-form) and C2´-endo (S-type, B-form) 
sugar conformations.146  
2´-F and 2´-SCF3 modifications can be incorporated into oligonucleotides using standard 
solid-phase oligonucleotide synthesis.94,107,142,143 2´-Deoxy-2´-fluoronucleosides 
predominantly adopt a C3´-endo sugar conformation that prefers RNA duplexes 
(A-form) (Figure 5b).147-150 Thus, a 2´-F substitution in an RNA duplex is usually 
structurally non-perturbing and slightly increases the stability of the double helix. The 
strong preference to C3´-endo pucker, however, affects the C2´/C3´-endo equilibrium, 
and a 2´-F modification may cause structural perturbations, for instance when positioned 
into a loop82. Compared to 2´-F modification, the 2´-SCF3 group is a more sensitive 
fluorine label with three magnetically equivalent and spin-isolated fluorine 
atoms.94,107,143 In contrast to 2´-F, the 2´-SCF3-substituted ribose favours a C2´-endo 
conformation and thus significantly decreases the stability of an RNA duplex.  
1.2.1.3 Other modifications 
A few 19F NMR studies have utilized non-nucleosidic modifications at the 5´-terminus 
(Figure 6). As discussed, 3,5-bis(trifluoromethyl)phenyl is a sensitive reporter group for 
19F NMR studies. This group has been incorporated via an appropriate linker into the 
5´-end of both DNA18,53 and RNA37 oligonucleotides using solid-phase synthesis, and 
the applicability of the group for the detection of G-quadruplexes has been 
demonstrated18,37,38. In addition, some preliminary 19F NMR studies have been conducted 
with oligodeoxynucleotide 5´-fluorodiphosphates.102  
 
Figure 6. Structures of non-nucleosidic fluorine modifications at the 5´-end of oligonucleotides. 
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1.2.2 19F NMR spectroscopy studies of nucleic acids 
1.2.2.1 Early studies and tRNA 
Horowitz and co-workers published their research on 5-fluorouridine-modified tRNA in 
197716, and in the same year, Marshall and Smith reported their 19F NMR studies on 
5-fluorouridine-modified 5S rRNA.15 Fluorine-labelled tRNAs were then extensively 
studied over the following years99,151-164, but little research was conducted with fluorine-
labelled 5S rRNA165. tRNA studies have primarily focused on Escherichia coli tRNAVal. 
5-Fluorouridine-substituted tRNAs were isolated from E. coli cells grown in the 
presence of 5-fluorouracil.16,166 This biosynthetic method provided tRNAs in which over 
90 % of uridine residues were replaced by 5-fluorouridine16, and this method was later 
replaced by enzymatic in vitro synthesis99. The fluorinated tRNAVal contained fourteen 
5-fluorouridine residues (Figure 7a).  
 
Figure 7. (a) 5-Fluorouracil-substituted E. Coli tRNAVal cloverleaf structure (residues that are 
replaced by 5-fluorouridine are indicated as grey spheres) (b) and its 19F NMR spectrum. (c) 19F 
NMR spectra of 5-fluorouracil-substituted E. Coli tRNAVal in the absence (thin line) and in the 
presence of valyl-tRNA-synthetase (solid line). Spectra reprinted with permission from Chu, W. 
C.; Horowitz, J. Biochemistry 1991, 30, 1655-1663. Copyright (1991) American Chemical 
Society.159 
In addition to currently employed modern NMR strategies (HOESY and 
NOESY)155,157,161, a variety of other approaches were used to assign the fluorine 
signals16,99,152-161. For instance chemical modification, pH dependency, solvent 
accessibility, mutation and interaction studies were performed16,99,152-161, and this 
laborious signal assignment was not completed until 1991-1992160,161. In summary, a 
variety of investigations were conducted with fluorine-labelled tRNAs, including studies 
a) b)
c)
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of tRNAVal-RNA153,156, tRNAVal-protein (cognate synthetase)159,163,164 (Figure 7b and c) 
and tRNAVal-small molecule154,162 binding interactions, ion induced conformational 
changes154,156,157 and temperature-dependent unfolding158, thus demonstrating the 
sensitivity of the fluorine to local environment and the diversity of 19F NMR-based 
approaches.  
1.2.2.2 Short oligonucleotides and conformational heterogeneity 
Many structural studies have utilized 19F-labelled nucleosides that are able to provide 
well-separated signals in single-stranded (ss) and double-stranded (ds) environments. 
Employing this labelling strategy, both the intra- and intermolecular secondary structure 
equilibria of short oligonucleotides have been successfully analysed by 19F NMR 
spectroscopy. Additionally, studies of more complex nucleic acid structures often rely 
on labels’ single strand-double strand recognition ability. 
Intramolecular hairpin-hairpin equilibria have been investigated to demonstrate the 
general ability of labels to distinguish coexisting nucleic acid structures quantitatively 
and to evaluate the influence of the fluorine modifications on nucleic acid structures. As 
a representative example, Figure 8 shows the 19F NMR spectra of 2´-F-labelled RNAs.142 
As observed, the 2´-F labels were sensitive to secondary structures, and unambiguous 
signals were detected for alternative hairpin conformers. Consequently, the ratios of 
coexisting conformers were easily determined from the relative peak areas of the 19F 
signals. However, the 2´-F pyrimidines shifted the equilibrium approximately 20-25 % 
toward the structures in which 2´-F pyrimidines exist in a double-helical region. In 
contrast, the equilibrium positions were unaffected with 2´-F purines.  
 
Figure 8. 19F NMR spectra (1H decoupled) of (a) 2´-F uridine (2´FU)- and (b) 2´-F guanosine 
(2´FG)-modified bistable RNAs and their reference hairpins. Reprinted and modified with 
permission from Kreutz, C.; Kählig, H.; Konrat, R.; Micura, R. J. Am. Chem. Soc. 2005, 127, 
11558-11559. Copyright (2005) American Chemical Society.142 
a) b)
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Furthermore, 5-fluoropyrimidine-modified DNA and RNA sequences adopting mutually 
exclusive hairpin structures have been investigated comprehensively.111 In each case, the 
5-fluoro pyrimidine label provided well separated 19F signals, and the equilibrium 
position remained unaffected, thus demonstrating the non-invasive nature of the 5-F 
modification. Interestingly, it was noted that the chemical shift difference between DNA 
folds (i.e., between ss and ds environments) was clearly smaller than the chemical shift 
difference between RNA folds. It was suggested that the difference between chemical 
shift dispersion was caused by the different stacking patterns within A- and B-form 
duplexes, and therefore the fluorine experiences a much larger environment change 
between RNA folds compared with DNA folds. Likewise, with the 2´-F and 5-fluoro 
pyrimidine labels, 2´-SCF3 labels have provided well-separated 19F signals for 
alternative hairpin structures, but the effect of the 2´-SCF3 group on the equilibrium 
position depends strongly on the labelling site.107,143  
The effect of the surrounding conditions to induce the dimerization of short 
oligonucleotides has also been analysed with 5-fluoropyrimidines. These studies have 
taken advantage of the suitability of 19F NMR spectroscopy to a variety of measurement 
conditions. For example, the dimerization of an RNA hairpin and its tethered model and 
corresponding DNA models (Figure 9a) were successfully investigated at different pH 
and in different Mg2+, Na+ and PEG400 (polyethylene glycol) concentrations.115,116 In 
another study the effect of Na+, K+, Sr2+, Mg2+, Ca2+ or Ba2+ on the hairpin-dimer 
equilibrium of an RNA was examined (Figure 9b).90 19F NMR data provided information 
on the contribution of electrostatic, entropic and enthalpic factors to the hairpin-dimer 
equilibrium and revealed that some of the cations induced formation of additional hairpin 
conformations.  
 
Figure 9. Schematic presentation of hairpin-dimer equilibria. (a) An RNA hairpin and its tethered 
model containing a 2´-deoxy-5-fluorouridine. In the case of DNA analogues U is T.  
(b) 5-Fluorouridine-modified RNA hairpin model of the translational operator of the MS2 
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In a recent study, 2´-deoxy-5-trifluoromethylcytidine and 2´-deoxy-5-trifluoromethyl-
uridine were used to probe a salt-induced formation of a left-handed Z-DNA.130 The 
labels were able to distinguish B-form, Z-form and ssDNA structures. Consequently, the 
distribution of these structures was easily determined from well-separated 19F signals in 
varying ionic conditions and different temperatures.  
The ability of the labels to discriminate between structural species has enabled the use 
of 19F NMR to study the thermal stability of nucleic acid structures. The melting of 
nucleic acid structures can be monitored in the fluorine signals upon stepwise 
heating33,34,93,158, and thermodynamic parameters19,37,90,96 and Tm values93 can be extracted 
from the temperature-dependent 19F NMR data. The Tm determination method93 has 
gained popularity and has been employed to characterize the melting behaviour of a 
variety of structures.19,24,36-39,55,89,94,95 This application was demonstrated with an 
intermolecular RNA duplex and an intramolecular RNA stem loop structure using a 
2,4-difluorotoluyl ribonucleoside.93 Melting of the intramolecular stem loop structure 
occurred in a fast exchange regime (Figure 10). When the chemical shift of the 19F signal 
was plotted against temperature, a sigmoidal curve was obtained, and the Tm value of the 
stem loop structure was obtained from its inflection point. The melting of the 
intermolecular duplex was in the slow exchange regime. The sigmoidal melting curve 
and thus the Tm value was obtained by plotting a fraction of a single strand against 
temperature. Importantly, in both cases, the Tm value was comparable with the value 
obtained by temperature-dependent UV spectroscopy. Additionally, it was 
simultaneously possible to monitor the temperature-dependent behaviour of coexisting 
structures from their distinct 19F signals. This is a clear advantage over traditional 
spectrophotometric methods (UV and CD)73-78, which often cannot provide information 
on the melting of coexisting structures. Compared to UV and CD spectroscopy, 19F 
reflects melting at a local level. Therefore, 19F NMR can be used to probe the 
temperature-dependent behaviour of a specific part of a nucleic acid structure, which 
typically is difficult with UV and CD spectroscopy. 1H NMR of imino protons can also 
be used for melting analysis, but spectral crowding and the Tm-independent exchange 
rate of the imino protons can interfere with this method.167,168 It should be noted that the 
chemical shift of 19F is inherently very sensitive to temperature11,59, and thus the 
temperature-dependent behaviour of the reporter group needs to be considered when 
analyzing the data24.  
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Figure 10. (a) 2,4-Difluorotoluyl ribonucleoside (rF)-modified intramolecular stem loop 
structure. (b) 19F NMR spectra (1H decoupled) at different temperatures. Only the signal of 
fluorine in position 4 is shown. (c) Melting profile obtained from the 19F NMR data. Reprinted 
and modified with permission from Graber, D.; Moroder, H.; Micura, R. J. Am. Chem. Soc. 2008, 
130, 17230-17231. Copyright (2008) American Chemical Society.93 
1.2.2.3 Spliceosomal U2-U6 snRNA complex 
The spliceosome is a ribonucleoprotein complex that removes introns from eukaryotic 
precursor messenger RNAs (pre-mRNAs) in a process called splicing.169 The 
spliceosome is composed of numerous proteins and five small nuclear RNAs (snRNAs), 
including U2 and U6 snRNAs. The interaction between U2 and U6 snRNAs creates the 
splicing scaffold. 5-Fluorocytidine has been employed to investigate the conformational 
heterogeneity of the protein-free human spliceosomal U2-U6 snRNA complex, 
specifically to investigate the formation of a four-helix conformation and a tree-helix 
conformation and to study the potential equilibrium between these conformers (Figure 
11).31,32 The 19F NMR spectrum of the U2-U6 snRNA complex exhibits a major 19F 
signal, which was attributed to a double-stranded form and thus indicates the formation 
of the four-helix junction conformation. In addition, a very broad signal was detected in 
the single-stranded region corresponding to the three-way junction conformation. The 
complexity of the signal was thought to originate from multiple alternative 
conformations or intermediates. Several fluorine-labelled mutation models were 
investigated to confirm the signal assignment. Because an analogous conformational 
equilibrium of the yeast complex has been shown to depend strongly on Mg2+ 
concentration, the effect of Mg2+ on the human U2-U6 snRNA complex was also 
investigated. In the presence of Mg2+ a slight shift in the equilibrium was detected; the 
percentage of the heterogeneous minor conformer increased from ~14% to ~17%. 
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Figure 11. Proposed secondary structures of the human U2-U6 snRNA complex model. The 19F 
NMR spectra of control RNAs and the U2-U6 snRNA complex in the absence and in the presence 
of magnesium. The 5-fluorocytidine (5FC) is in red. Reprinted and modified with permission from 
Zhao, C.; Bachu, R.; Popović, M.; Devany, M.; Brenowitz, M.; Schlatterer, J. C.; Greenbaum, N. 
L. RNA 2013, 19, 561-573. © 2013 RNA Society.31  
Two-dimensional 19F-19F EXSY (exchange spectroscopy) experiments were additionally 
conducted to obtain information about conformational exchange dynamics32; this 
method had previously been successfully applied to the hairpin-hairpin equilibria of a 
short 5-fluorouridine-modified RNA97. The 19F-19F EXSY data indicated that there was 
a dynamic exchange between different conformations, but the complexity and low 
quality of the spectra prevented more detailed kinetic analysis.32 Overall, the 19F NMR 
results were consistent with biochemical studies.31,32 It was concluded that the 
predominant four-helix conformation is in dynamic equilibrium with the minor three-
helix conformation, and facile interconversion between these conformations occurs. 
1.2.2.4 Riboswitches 
Riboswitches are ligand-sensing regulatory elements most commonly found in the 
noncoding regions of some bacterial mRNAs.170,171 A typical riboswitch consists of two 
domains: an aptamer domain, which contains a selective high-affinity binding site for a 
ligand, and an adjoining expression platform, which controls gene expression. The 
formation of a stable aptamer-ligand complex induces conformational changes in the 
expression platform and leads to the regulation of gene expression. 19F NMR 
spectroscopy has been used to investigate bacterial riboswitches, including preQ1 class I 
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a guanine-sensing riboswitch29, and an artificial tobramycin-sensing riboswitch107. 
Conformational equilibria of the riboswitches in the absence and presence of ligands can 
be detected and quantified by 19F NMR analysis and complemented by other detection 
methods to offer insight into folding pathways. In addition, 19F NMR has provided 
information about how different factors, such as Mg2+ ions27,28,94, temperature27,28, base 
mutations28 or competitive artefact28, affect structural equilibria. The preQ1 class I 
riboswitches are discussed in more detail below; 19F NMR spectroscopy has been applied 
to the detection of both aptamer-ligand complexes28,94,111 and structural changes in the 
expression platform in response to ligand binding26.  
The minimal aptamer domain (34 nt) of a Fusobacterium nucleatum preQ1 class I 
riboswitch forms a pseudoknot structure upon 7-aminomethyl-7-deazaguanine (preQ1) 
binding.172 19F NMR spectroscopy was used to analyse the structural behaviour of the 
wild-type aptamer and its mutant form (a single base pair mutation, A33G/U9C, Figure 
12b) using 5-fluoro pyrimidine labels.28 The 19F NMR data indicated that the mutant 
aptamer adopted two conformational states in the absence of preQ1 (Figure 12b), and 
this result was further confirmed with 1H and 15N NMR spectroscopy. In addition to the 
stem-loop structure, the aptamer adopted a pseudoknot conformation that structurally 
resembles the ligand-bound complex and exists in a slow dynamic equilibrium with the 
stem-loop structure. The pseudoknot formation stabilized at a low temperature and in 
the presence of Mg2+ ions.  
 
Figure 12. Comparison of the conformational behaviour of wild-type and mutant F. nucleatum 
preQ1 riboswitch aptamers. 1H NMR and 19F NMR spectra of free (upper) and preQ1-bound 
(lower) (a) 5-fluorouridine-modified wild-type RNA and (b) 5-fluorocytidine-modified mutant 
RNA. Proposed structures are shown. Spectra reprinted and modified with permission from 
Santner, T.; Rieder, U.; Kreutz, C.; Micura, R. J. Am. Chem. Soc. 2012, 134, 11928-11931. 
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The 19F NMR data showed that the wild-type aptamer was unable to adopt a preorganized 
pseudoknot structure.28 Instead, a clear indication of a proposed dimeric structure was 
observed. As observed in Figure 12a, the dimer was a dominant structure in the absence 
of the ligand. In addition, a trace of the dimer was detected in the presence of preQ1, 
whereas only the 19F signal attributed to the preQ1 complex was observed for the mutant 
aptamer (Figure 12b). This difference thought to be caused by the single base pair 
mutation because it not only stabilizes the pre-organized pseudoknot fold but also 
destabilizes the dimer formation. The dimer was assigned as an artefact formed in high 
RNA concentrations, and it was confirmed using a fluorescence experiment that the 
wild-type aptamer adopted a pre-organized pseudoknot structure in the presence of 
magnesium at a low RNA concentration (0.5 µM versus 600 µM used in 19F NMR 
experiments). The direct evidence of a competitive structure provided an explanation for 
data previously obtained by small-angle X-ray scattering. Similarly, ligand-free state, a 
Mg2+-induced pseudoknot structure and a ligand bound state (preQ1) of another preQ1 
class I riboswitch aptamer domain have been successfully monitored with a 2´-SCF3 
guanosine (Figure 13a).94  
 
Figure 13. (a) 19F NMR and 1H NMR analysis of ligand-free, Mg2+-induced pseudoknot fold and 
preQ1-bound state of 2′-SCF3 guanosine-modified Thermoanaerobacter tengcongensis preQ1 
class I riboswitch. Reprinted and modified with permission from Jud, L.; Košutić, M.; Schwarz, 
V.; Hartl, M.; Kreutz, C.; Bister, K.; Micura, R. Chem. Eur. J. 2015, 21, 10400-10407 © 2015 
The Authors.94 (b) 5-Fluorouridine-modified bistable secondary structure model of the 
F. nucleatum preQ1 riboswitch. The minimal aptamer domain (grey bold letters, same as Figure 
12a) and the bistable hairpin sequence within the expression platform (black bold letters) share a 
single nucleotide (G34 underlined). The binding of preQ1 (aptamer domain adopts a preQ1-bound 
state) shifts the equilibrium position towards the lower stem-loop structure (i.e., termination 
hairpin). 
a) b)
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19F NMR spectroscopy has also been used to detect the ligand-induced rearrangement 
on the expression platform of the F. nucleatum preQ1 class I riboswitch (Figure 13b).26 
Chemical and enzymatic structural probing indicated that the expression platform 
contains a hairpin-hairpin equilibrium that is sensitive to ligand-induced rearrangement 
at the aptamer domain. Since a full-length riboswitch (61 nt) was also required for more 
detailed investigations, 1H NMR spectroscopy was unsuitable method because of 
spectral crowding. Using 5-fluorouridine labelling, it was possible to confirm that the 
expression platform adopted a hairpin-hairpin equilibrium and to directly monitor the 
preQ1-induced changes in the equilibrium position.  
1.2.2.5 Hammerhead ribozyme 
The metal ion-induced folding of hammerhead ribozyme has been monitored by 19F 
NMR to obtain local information on the folding process.30 Hammerhead ribozyme is a 
small catalytic RNA that undergoes autocatalytic self-cleavage in the presence of Mg2+ 
ions. The catalytic core of the minimal hammerhead ribozyme is flanked by three helical 
stems. To acquire a functional conformation the core undergoes structural 
rearrangements in the presence of Mg2+ ions. One of the 2´-O-methyl-5-fluorouridines 
(U4 in Figure 14) was introduced into domain 1 and the other was located at the interface 
between domains 1 and 2 (U7 in Figure 14) of the cloverleaf construct.  
 
Figure 14. Schematic presentation of a two-stage folding process for a hammerhead ribozyme. 
The 2´-O-methyl-5-fluorouridines U4 and U7 are shown as green spheres. Crystal structure of 
hammerhead ribozyme. Reprinted and modified with permission from Hammann, C.; Norman, 
D. G.; Lilley, D. M. J. PNAS 2001, 98, 5503-5508. Copyright (2001) National Academy of 
Sciences.30 
Both of the labels were sensitive to titration with Mg2+ ions; thus, it was possible to 
monitor the folding process from the chemical shifts and linewidths. With label U7, two 
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different transitions were detected upon the addition of Mg2+ ions. The first transition at 
a low Mg2+ concentration (500 µM) was attributed to an initial folding event i.e., the 
formation of domain 2. As the linewidth of the signal significantly broadened between 
0 and 500 µM Mg2+, and then subsequently narrowed between 500 µM and  
1 mM Mg2+, the folding process was interpreted as an intermediate exchange regime 
(a 500 MHz instrument was used for the analysis). It was estimated that the formation 
of domain 2 occurs on approximately the millisecond timescale. The second transition 
was detected at millimolar Mg2+ concentrations. The same transition was also observed 
with label 4, and thus, it was attributed to the formation of domain 1. The chemical shift 
data of the second transition showed non-cooperative binding of Mg2+ ions with apparent 
association constants of approximately 100-500 M-1. In summary, the 19F NMR data 
supported the two-stage ion-induced folding mechanism in which the sequential 
conformational transitions of domains 2 and 1 create the active conformation of the 
minimal hammerhead ribozyme. 
1.2.2.6 Trans-activation response element 
The trans-activation response element (TAR) is a conserved RNA stem loop structure 
found at the beginning of human immunodeficiency virus (HIV) transcripts.173 The 
interaction between TAR and the viral protein Tat has an essential role in viral 
transcription, and TAR has been extensively studied as a potential therapeutic 
target.174,175 19F NMR spectroscopy has been used to investigate the binding of metal 
ions20, argininamide20,25 and invader oligonucleotides24,89 to fluorine-labelled TAR 
models. In addition, solid-state 19F NMR spectroscopy has been applied to investigate 
Tat peptide-TAR interactions.22,64,65  
Metal ion-TAR interactions have been explored using 5-fluorouridine-modified HIV 
type-1 (HIV-1) TAR models (Figure 15).20 Several 5-fluorouridines were introduced 
within TAR models to determine the binding sites and Kd values for metal ions (Mg2+, 
Ca2+ and Co(NH3)63+). The applicability of this approach was first evaluated by 
monitoring the chemical shift changes induced by the known TAR ligand argininamide 
as a function of its concentration. Identifying the locations of binding sites for small 
molecules has also been conducted previously with other RNA targets.162,176 
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Figure 15. (a) 5-Fluorouridine-modified HIV-1 TAR models and (b) their 19F NMR spectra. 
Spectra reprinted and modified from Olejniczak, M.; Gdaniec, Z.; Fischer, A.; Grabarkiewicz, T.; 
Bielecki, L.; Adamiak, R. W. Nucleic Acids Res. 2002, 30, 4241-4249, by permission of Oxford 
University Press Copyright 2002, Oxford University Press.20 
Structural studies have shown that the bulge region undergoes major structural 
rearrangement upon the binding of argininamide (Figure 16b and c).177-179 The residue 
U23 undergoes significant secondary structural rearrangement and may participate in 
base triplet (U23-A27-U38) formation within the argininamide-TAR complex. As 
expected, titration experiments showed that the labelled residues positioned within the 
bulge region (i.e., FU-23, FU-25, FU-38 and FU-40) were sensitive to the addition of 
argininamide, whereas negligible changes were observed for residue FU-31, which is 
positioned at the loop.20 Notably, a large chemical shift change was detected for FU-23. 
Because the argininamide titration experiment was consistent with structural studies and 
was able to provide site-specific information, the binding of Mg2+, Ca2+ and Co(NH3)63+ 
ions was investigated by the same technique. The titration data showed that the metal 
ions bind to the bulge region. In addition, the Kd values for argininamide (0.3 mM), Mg2+ 
(0.9 mM) and Ca2+ (2.7 mM) were obtained from the titration data. Co(NH3)63+ caused 
the irreversible aggregation of RNA, and thus its Kd value could not be determined. 
A similar approach was successfully used to investigate the argininamide binding in 
uniformly labelled HIV-2 TAR models (Figure 16a).25 The concept was the same as 
described above; 19F chemical shift changes were followed upon the consecutive 
addition of argininamide, and the obtained data were used for the localization of the 
binding site and to determine the Kd values. It was proposed that this technique could be 
used to identify novel TAR-binding small molecules. In addition to the studies with 
uniformly labelled tRNAs, this is one of the few examples that has utilized a uniform 
labelling strategy. These TAR models have also been used for solvent accessibility 
19F NMR spectra
a) b)
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measurements (i.e., solvent-induced isotope shift (SIIS) studies) and detailed structural 
studies.21,23,25,83 
 
Figure 16. (a) Uniformly labelled HIV-2 TAR models. Structures of unlabelled (b) HIV-1 TAR 
(PDB ID 1ANR)177 and (c) HIV-2 TAR argininamide (cyan) complex (PDB 1AJU)179. Residues 
U23, A27 and U38 are coloured to illustrate the secondary structure rearrangement of the bulge 
region. Consistent numbering is used for the HIV-1 (bulge U23, C24, U25) and HIV-2 (bulge 
U23, U25) TAR models. 
As described above, residue U23 is part of a marked secondary structural rearrangement 
upon the binding of argininamide. Similarly, Tat peptide binding induces a significant 
conformational rearrangement at the bulge region and affects the position of residue 
U23.180,181 The binding of Tat peptide has been monitored by rotational-echo double-
resonance (REDOR) NMR using fluorine-labelled HIV-1 TAR models.22,64,65 REDOR 
NMR is a solid-state NMR technique for measuring dipolar couplings and hence 
distances between a heteronuclear spin pair. Using a 31P-19F REDOR experiment, the 
distance between a 2´-F-modified U23 and a phosphorothioate modified A27 was shown 
to change from 10.3 to 6.6 Å upon Tat peptide binding.22 In addition, the Tat-TAR 
interactions were investigated by combining several REDOR experiments using 15N- and 
13C-labelled Tat peptide and a 5-fluorouridine-modified TAR model.64,65 Both the 
intramolecular22 and intermolecular64,65 distances were comparable with solution NMR 
studies, thus demonstrating the utility of the REDOR method to study RNA-peptide 
interactions and RNA conformational changes.  
The invasion of 2´-O-methyl oligoribonucleotides into a fluorine-labelled HIV-1 TAR 
model is a more complex example of an intermolecular nucleic acid-nucleic acid 
interaction that has been successfully monitored by 19F NMR.24,89 The invasion of 
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macro-loop invasion complex (Figure 17a and 17b), and Kd values could be extracted 
from the titration data. Thus, 19F NMR provided a direct way to compare the ability of 
different oligonucleotides to invade the fluorine-labelled TAR model. The invasion was 
also monitored in the presence of the aminoglycoside neomycin. Neomycin is known to 
bind to the minor groove below the bulge. It was suggested that this interaction might 
affect the invasion, and titration data confirmed that neomycin clearly promoted the 
invasion. Moreover, it was later shown that the covalent conjugation of neomycin to 
2´-O-methyl oligoribonucleotides significantly promotes invasion.89 In addition to 
titration studies, the temperature-dependent behaviour of invasion complexes was 
monitored by 19F NMR.24,89 As illustrated in the Figure 17a, the macro-loop invasion 
complex/open chain invasion complex/single strand conversion is coupled to the 
hairpin/single strand conversion, and thus the overall melting process is a highly 
complex, in particular when the interaction between the invader and TAR is weak. The 
applicability of 19F NMR spectroscopy for monitoring these dynamic intramolecular and 
intermolecular equilibria was demonstrated.  
 
Figure 17. (a) Schematic presentation of the invasion of 8 mer 2´-O-methyl oligoribonucleotide 
into a 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-2´-deoxyuridine-modified HIV-1 
TAR model  (boxed) and the temperature-dependent behaviour of the invasion complexes. 
(b) The 19F NMR spectra upon the titration of 2´-O-methyl oligoribonucleotide. Reprinted and 
modified with permission from Kiviniemi, A.; Virta, P. J. Am. Chem. Soc. 2010, 132, 8560-8562. 
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1.2.2.7 DNA triple helix 
Triple-helical nucleic acid structures are formed when a third strand (i.e., triplex-forming 
strand) binds a sequence-specifically in the major groove of a double-helical nucleic acid 
structure.182-184 (A brief description of triple helices is presented in Section 3.2.1). 
A pyrimidine motif DNA triplex has been studied by 19F NMR spectroscopy using a 
2´-deoxy-5-fluorouridine-modified third strand (Figure 18).35 Because the formation of 
C-rich pyrimidine motif triplexes requires the protonation of the cytosine bases185-189, the 
model is strongly pH-dependent and stabilized under acidic conditions.  
 
Figure 18.  Schematic presentation of triplex formation and 19F NMR spectra of 2-deoxy-
5-fluorouridine-substitued single strand alone (A and E) and in the presence of duplex (B, C and 
D). Spectra reprinted and modified from Tanabe, K.; Sugiura, M.; Nishimoto, S. Bioorg. Med. 
Chem. 2010, 18, 6690-6694, Copyright (2010), with permission from Elsevier.35 
The 19F-NMR spectra of the third strand alone was complex and multiple signals 
indicated the formation of secondary structures (Figure 18).35 These signals were 
attributed to non-specific structures, because C-rich strands can adopt unspecified 
structures under acidic conditions190,191. This suggestion was further confirmed by the 
fact that a single 19F signal was observed at a neutral pH or at an elevated temperature. 
The association of the third strand to the DNA duplex at 25 °C and the dissociation of 
the third strand upon heating could be clearly detected from distinct 19F chemical shifts. 
As a result, this labelling choice allowed the detection of triplex and single-stranded 
structures and to some extent, competitive unspecified structures. These results 
demonstrated that DNA triplexes can be monitored by 19F NMR. In another study, 
neomycin-conjugated triplex-forming oligonucleotides were investigated by 19F NMR 
spectroscopy.36 This work has been conducted in our laboratory; some of the preliminary 
work is included in the Results and Discussion Section and thus it is not presented here.  
triplex
single strand
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1.2.2.8 G-quadruplexes 
G-quadruplexes are four-stranded nucleic acid structures formed by G-rich DNA and 
RNA sequences.192-194  These topologically diverse structures have received considerable 
attention due to their possible biological roles, for instance, in replication, translation, 
telomere biology and transcription.193,195-201 A short description of G-quadruplexes is 
presented in Section 3.5. 
A dimeric model of a human telomeric RNA G-quadruplex has been studied with a 
3,5-bis(trifluoromethyl)phenyl label (Figure 19a).37 A single 19F signal assigned to a 
dimeric G-quadruplex was observed at a low RNA concentration, and an additional 
signal was detected at a higher RNA concentration (Figure 19b). This 19F signal was 
attributed to a higher-order G-quadruplex in which two dimeric G-quadruplex subunits 
are stacked together. Consequently, the 19F NMR allowed the behaviour of the dimeric 
and stacked G-quadruplex structures to be investigated simultaneously in various 
conditions. 
 
Figure 19. (a) Structure of 19F-labelled telomere RNA. According to CD spectroscopy the 
labelling did not affect the G-quadruplex structure, but the Tm values were not reported. (b) 19F 
NMR spectra and (c) 1H NMR spectra of labelled RNA at different concentrations. (d) 19F NMR 
spectra of labelled RNA in vitro, within Xenopus laevis oocyte extract and in Xenopus laevis 
cells. The peaks corresponding to dimeric G-quadruplex are marked with red dots and those of 
the stacked G-quadruplex with green dots. (e) Structure of pyridostatin. Reprinted and modified 
with permission from Bao, H.; Ishizuka, T.; Sakamoto, T.; Fujimoto, K.; Uechi, T.; Kenmochi, 
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The temperature-dependent conversion of stacked G-quadruplex/dimer 
G-quadruplex/single strand was monitored by 19F NMR.37 Tm values of 52.4 °C and 
67.8 °C were obtained for stacked and dimeric G-quadruplex, respectively, at a 3.0 mM 
concentration. Moreover, thermodynamic parameters were extracted from the 
temperature-dependent 19F NMR data by applying van’t Hoff analysis. The 
thermodynamic parameters indicated that the stabilizing stacking interactions are of an 
enthalpic origin. In particular, the ∆H value for the stacking interaction between two 
G-quadruplex subunits (∆H -61.8 kJ/mol) was nearly comparable to the formation of the 
single G-tetrad (∆H -86.9 kJ/mol).  
Interestingly, the conformational behaviour of the G-quadruplex was investigated in 
cells using 19F NMR spectroscopy (i.e., in-cell 19F NMR experiment).37 The 19F-labelled 
RNA was injected into Xenopus laevis oocytes. The single observable 19F signal 
associated with stacked G-quadruplex demonstrated that the higher-order G-quadruplex 
structure was formed in living cells (Figure 19d). Similarly, the 19F signal of the stacked 
G-quadruplex was also detected in oocyte lysate. The stacked G-quadruplex-dimeric 
G-quadruplex equilibrium was additionally investigated under molecular crowding 
conditions. The 19F NMR data showed that molecular crowding agents, including 
acetonitrile, dimethyl sulfoxide, ethanol and PEG200, induced and stabilized the 
formation of a stacked G-quadruplex structure. The binding of a well-known 
G-quadruplex binding molecule, pyridostatin (Figure 19e), to dimeric and stacked 
G-quadruplexes was also studied.38 The binding stoichiometry (including Kd values) and 
temperature-dependent behaviour of the complexes could be monitored by 19F NMR 
spectroscopy. The results indicated that pyridostatin preferably binds to the dimeric 
rather than the stacked G-quadruplex. Finally, it was demonstrated that interaction 
between a telomeric repeat binding protein and the dimeric G-quadruplex was detectable 
by 19F NMR.  
DNA G-quadruplexes have also been investigated by 19F NMR spectroscopy. The 
intended purpose of the 5´-end 3,5-bis(trifluoromethyl)phenyl-modified thrombin 
binding aptamer (TBA) was to use it as a potassium ion sensor (Figure 20a).18 A unique 
19F signal was detected that responded to K+ addition in a concentration-dependent 
manner. Unfortunately, the modification decreased the thermal stability of TBA 
(∆Tm -7.0 °C compared to native TBA) and thus reduced the detection range of 
potassium ions. In a recent study, TBA was investigated with a 19F-modified guanine 
derivative (Figure 20b), and as expected, the derivative stabilized the G-quadruplex (∆Tm 
+5.0 °C compared to native TBA).39 Like the 5´-end modification, the guanine label was 
clearly able to distinguish single-stranded and G-quadruplex structures. In addition to 
TBA, the formation of intermolecular human telomeric DNA G-quadruplex structures 
was monitored with the guanine label. The derivative was also used to monitor the 
thermal melting of telomeric DNA G-quadruplex and for the detection of G-quadruplex 
structures in Xenopus laevis oocytes. In another recent study, the thermodynamic 
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properties of 5-[(3,5-bis(trifluoromethyl)phenyl)ethynyl]-2´-deoxyuridine-modified 
TBAs were analysed by 19F NMR (Figure 20c).19 
 
Figure 20. 19F-labelled thrombin binding aptamers. (a) A non-nucleosidic fluorine modification 
at the 5´-end of TBA. (b) 8-[(3,5-Bis(trifluoromethyl)phenyl)ethynyl]-2´-deoxyguanosine-
modified TBA. (c) 5-[(3,5-Bis(trifluoromethyl)phenyl)ethynyl]-2´-deoxyuridine, which has been 
incorporated in place of one of the thymidine residues within TBA. 
1.2.2.9 Protein-nucleic acid interactions 
Nucleic acid-protein interactions play fundamental roles in biology, and similar to 
nucleic acid-nucleic acid interactions, 19F NMR spectroscopy can elucidate the structural 
and dynamic properties of these macromolecule complexes. 19F NMR data have 
provided information about binding sites and interactions as well as conformational 
changes and structural distortions. These studies include interactions between E. coli 
tRNAVal and its cognate synthetase159,163,164, between bacteriophage T7 RNA polymerase 
and its promoter109, between Lambda phage cro repressor and its operator DNA OR3112,113 
and between E. coli lac repressor and its lac operator114.  
In addition to probing binding interactions, 19F NMR spectroscopy has been successfully 
used to investigate the dynamic conformational behaviour of enzyme-DNA 
complexes.117,118,134 For example, 19F NMR spectroscopy has been exploited to 
investigate the flipping of cytosine by DNA cytosine-5 methyltransferase HhaI 
(M.HhaI).118 The dynamic conformational behaviour of the target cytosine (for 
methylation) in the binary (DNA-enzyme) and ternary (DNA-enzyme-cofactor) 
complexes was investigated by replacing it with 5-fluorocytosine (Figure 21a). 19F NMR 
and gel shift mobility data revealed three conformational states for the 5-fluorocytosine: 
a stacked conformation in the DNA duplex, an ensemble of extrahelical flipped-out 
conformations, and an extrahelical flipped-out locked conformation in the enzyme active 
site. In particular, the binding of a cofactor analogue S-adenosyl-L-homocysteine 
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(AdoHcy) to the binary complex (i.e., the formation of a ternary complex) induced the 
formation of the extrahelical locked conformation (Figure 21b). This conformation was 
clearly detected by 19F NMR spectroscopy because a new signal appeared approximately 
11 ppm from the signal of the stacked 5-fluorocytosine. Because the data indicated that 
the base flipping was not solely dependent on the binding of the cytosine in the active 
site of the enzyme, it was proposed that the enzyme has an active role in the opening of 
the DNA duplex. 
 
Figure 21. (a) 19F-labelled DNA used to investigate base flipping. The recognition site of the 
methyltransferase is boxed. The target cytosine was replaced by 5-fluorocytosine, and the other 
5-fluorocytosine served as an internal reference. A cytosine of the complementary strand was 
methylated to prevent interaction of the enzyme with that cytosine. (b) Structure of the ternary 
M.HhaI (light grey)-DNA (dark grey, flipped out cytidine residue is in cyan)-AdoHcy (black) 
complex with non-labelled DNA sequence (PDB ID 3MHT202).  
In addition, 19F NMR spectroscopy has been utilized to investigate the conformational 
dynamics of vaccinia type IB topoisomerase-DNA117 and uracil DNA glycosylase-
DNA134 complexes. The catalytic mechanism of tRNA methylation has also been 
investigated.110 All of these studies mentioned above were conducted between 1985 and 
2004, and despite these early studies, this area has gained little interest during the last 
decade. Recent studies have demonstrated the capability of labels to detect the formation 
of protein-nucleic acid complexes.19,38,101,107 For example, the interaction between DNA 
duplex and a core domain of p53 (a tumour suppressor protein203) was monitored with a 
5-[4-(trifluoroacetyl)phenyl]-2´-deoxycytidine.101 Protein-nucleic acid complexes have 
also been investigated using fluorine-labelled proteins.204,205 
1.2.2.10  DNA adducts 
Arylamines are mutagenic compounds that form covalent adducts with DNA in vivo and 
have been implicated in the development of various cancers.206,207 The “adducted DNA” 
a) b)
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can adopt multiple conformers that exist in dynamic equilibria, and the mutagenicity 
partly originates from this conformational heterogeneity. 19F NMR spectroscopy has 
been used to investigate the complex conformational behaviour of FAF, FAAF and 
FABP adducts, which are fluorinated analogues of extensively studied C8-substitued 
deoxyguanosine arylamine DNA adducts of 2-aminofluorene and 4-aminobiphenyl 
(Figure 22a).33,34,96,208-221 19F NMR spectroscopy has enabled the direct detection of 
various conformations and revealed how the distribution and stability of the conformers 
depend on surrounding features, such as DNA sequence composition or temperature 
(Figure 22b and c). 19F NMR in conjunction with other detection methods has provided 
valuable insight into conformational heterogeneity and how a certain adduct affects the 
mutagenic and repair outcomes. 
 
Figure 22. (a) Structures of FAF [N-(2´-deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene], FAAF 
[N-(2´-deoxyguanosin-8-yl)-7-fluoro-2-acetylaminofluorene] and FABP [N-(2´-deoxyguanosin-
8-yl)-4´-fluoro-4-aminobiphenyl] adducts. (b) Conformational states adopted by non-fluorinated 
FAF. A major groove B-type conformation (B) and a stacked conformation (S). (c) 19F NMR 
spectra of FAF (grey G) modified DNA duplexes in different sequence contexts (the inverted 
base pair is circled). Reprinted and modified from Jain, V.; Hilton, B.; Lin, B.; Patnaik, S.; Liang, 
F.; Darian, E.; Zou, Y.; MacKerell, A. D.; Cho, B. P. Nucleic Acids Res. 2013, 41, 869-880 by 
permission of Oxford University Press © The Authors 2012.217 
1.2.2.11  Peptide nucleic acid-nucleic acid interactions 
Peptide nucleic acids (PNAs) are synthetic homologs of nucleic acids in which the 
phosphate-sugar backbone is replaced by a peptide-like backbone.222 As illustrated in 
Figure 23a, PNAs can form a triplex structure via strand invasion in addition to triplex. 
19F NMR has been used to investigate interactions between triplex-forming peptide 
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conducted in our laboratory and the used fluorine-modified nucleoside analogues are 
presented in the Results and Discussion Section). Using 19F NMR, it was possible to 
distinguish these triplex structures and thus analyse the binding modes of differently 
modified TFPNAs. 19F NMR provided information about binding stoichiometry, 
transitions between binding modes, and the temperature-dependent behaviour of 
coexisting complexes.  
 
Figure 23. (a) Schematic presentation of PNA triplexes. PNA sequences are represented in bold. 
(b) Fluorinated PNA analogues. 
In addition, PNA-nucleic acid interactions have been investigated by incorporating a 
fluorine label into the PNA (Figure 23b).223 Using this strategy, 19F NMR spectroscopy 
was successfully applied to monitor the hybridization of fluorine-labelled PNAs with 
complementary parallel or antiparallel RNA or DNA sequences and to monitor more 
complicated competitive hybridization processes. 
1.2.2.12 Hybridization probes 
Fluorine-labelled oligonucleotides have been used as 19F NMR-based hybridization 
probes to detect target sequences and structural distortions. A variety of approaches have 
been described. In one strategy, a photo-cross-linking-induced 19F chemical shift change 
was combined with a hybridization chain reaction.56 Using this strategy it was possible 
to detect miRNAs at a nanomolar level using 3-cyanovinylcarbazole- and 2´-deoxy-
5-trifluoromethyluridine-modified DNA probes (Figure 24a). In a different approach, a 
potential DNA hybridization probe for MRI was designed to utilize a paramagnetic 
relaxation enhancement effect.53 As illustrated in Figure 24b, the probe adopts a hairpin 
structure in which close proximity of a 3´-end chelate to the 5´-end fluorine moiety was 
shown to quench the 19F signal, whereas a detectable 19F signal was observed upon 
hybridization with a target sequence. Additionally, fluorinated DNA-polymer 
conjugates57 and fluorinated DNA gold nanoparticle complexes54 have been proposed as 
potential MRI probes.  
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Figure 24. (a) Photo-cross-linking reaction between 3-cyanovinylcarbazole and 2´-deoxy-
5-trifluoromethyluridine. (b) Schematic presentation of the mechanism of a DNA probe 
containing a fluorine and a chelate part. 
3,5-Bis(trifluoromethyl)phenyl-modified oligodeoxynucleotides have been used as 
hybridization probes to detect DNA mismatches and single nucleotide bulges 
(Figure 25).55 In this approach the hybridization of the probe with the target sequences 
is expected to provide a characteristic 19F signal for each structure. As summarized in 
Figure 25, both of the probes were able to distinguish some of the distortions, but the 
discrimination ability of the fluorine moiety was better with a longer linker. 
 
Figure 25. 3,5-Bis(trifluoromethyl)phenyl-modified hybridization probes and investigated 
mismatch and bulge structures. The non-complementary sequences that were recognized are 
presented below the labels.  
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In contrast to the hybridization probes discussed above, fluorinated 2´-deoxy-
N4-(6-aminopyridin-2-yl)cytidine-modified triplex-forming oligodeoxynucleotides have 
been used to recognize mismatches in double-stranded DNA structures.58 One of the 
cytidine derivatives and its interaction with a duplex is shown in Figure 26. This probe 
was able to distinguish fully complementary sequence and all three mismatch structures 
simultaneously.  
 
Figure 26. The proposed interaction of fluorinated 2´-deoxy-N4-(6-aminopyridin-2-yl)cytidine 
derivative with the DNA duplex. (• Hoogsteen hydrogen bonding) 
1.3 External fluorine probes 
Fluorinated small molecules have been proposed as an alternative approach to internal 
fluorine probes.224 One advantage of small molecule external probes is that the labelling 
of the target nucleic acid is avoided. However, the obvious challenge of this approach is 
to find a suitable fluorinated small molecule that readily reflects the process of interest. 
The concept of this approach has been demonstrated with fluorinated 
diaminocyclopentanes224, but the use of external fluorine probes as structural probes has 
received little interest thus far.  
The interaction of racemic fluorinated diaminocyclopentanes (Figure 27a) with tRNALys3 
was investigated by 19F NMR to evaluate their properties as external 19F NMR probes.224 
Among these compounds, a (±)-4-fluorocyclopentane-1,3-diamine was the most 
sensitive probe. Its interaction with tRNALys3 led to a chiral resolution and distinct 19F 
signals were observed for each enantiomer (Figure 27b). 1H NMR and TROSY 
(transverse relaxation optimized spectroscopy) measurements revealed, that the 
enantiomers bind at the same binding site located in the T-arm with Kd values in the 
millimolar range.  
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Figure 27. (a) Structures of fluorinated diaminocyclopentanes. (b) 19F NMR spectra of 
()-4-fluorocyclopentane-1,3-diamine (rac 2a refers to ()-4-fluorocyclopentane-1,3-diamine) 
with tRNALys3 D-arm, tRNALys3 T-arm and tRNALys3. Reprinted and modified with permission 
from Moumné, R.; Pasco, M.; Prost, E.; Lecourt, T.; Micouin, L.; Tisné, C. J. Am. Chem. Soc. 
2010, 132, 13111-13113. Copyright (2010) American Chemical Society.224 
The applicability of ()-4-fluorocyclopentane-1,3-diamine as a structural probe was 
further demonstrated by monitoring its interaction with other tRNAs including E.coli 
tRNAfMet and tRNAMet and yeast tRNAPhe.224 A different signal splitting was observed in 
each case, demonstrating the sensitivity of the probe to its local environment. In addition, 
()-4-fluorocyclopentane-1,3-diamine was successfully used to monitor the thermal 
melting of the T-arm hairpin. The non-invasive properties of ()-4-fluorocyclopentane-
1,3-diamine were also demonstrated by analysing its interaction with neomycin 
aptamer.52 Neomycin aptamer adopts a less structured conformation in the absence of a 
ligand and upon neomycin binding adopts a well-structured conformation. 1H NMR 
experiments showed that the interaction of ()-4-fluorocyclopentane-1,3-diamine with 
the neomycin aptamer did not affect conformational equilibrium whereas a higher 
affinity probe clearly shifted the equilibrium towards a bound state. Because the 
()-4-fluorocyclopentane-1,3-diamine was displaced upon neomycin binding, it was 
possible to monitor the conformational capture of the aptamer via its 19F signals. It was 
proposed that this concept might be suitable for investigating riboswitches. The 
()-4-fluorocyclopentane-1,3-diamine has also been employed in ligand binding studies 
(Section 1.4). 
Another example of an external fluorine probe is 3,5-bis(trifluoromethyl)phenyl-
modified bisbenzimide H 33258 (Figure 28a).225,226 It is a dual probe designed to 
discriminate between dsDNA structures. In contrast to ()-4-fluorocyclopentane-
1,3-diamine, its interaction with the target is not based on a weak non-invasive 
interaction. Bisbenzimide H 33258 (Hoechst 33258) is a well-known fluorescent agent 
that binds to the minor groove of an AATT region of dsDNA. The 19F NMR data showed 
that the 19F shift of the probe was sensitive to the adjacent base-pairs of the AATT 
binding site (Figure 28b) and it was demonstrated that all four neighbouring base pairs 
were recognized in a mixture of sequences.225 Moreover, it was shown that the probe 
a) b)
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could distinguish single nucleotide bulge structures near the AATT binding site (Figure 
28c) and thus provide characteristic 19F signals for each structure.226 
 
Figure 28. (a) Structure of 3,5-bis(trifluoromethyl)phenyl-modified bisbenzimide H 33258. (b 
and c) Investigated structures. Binding site of the probe is shown. 
1.4 Small molecule binding studies 
Nucleic acid structures are attractive targets for small molecules, and 19F NMR-based 
methods have also been used to investigate small molecule-nucleic acid interactions. 
The studies employing internal fluorine probes have focused on investigating known 
small molecule-nucleic acid interactions.17,20,25,38,162,176 Previously mentioned TAR-
argininamide20,25 and G-quadruplex-pyridostatin38 interactions are examples. In addition, 
several examples have been reported in which 19F NMR spectroscopy has been utilized 
to provide detailed information on the binding interactions of fluorinated small 
molecules62,227-238, such as fluorinated daunomycin234-237 or tripeptide231,232 or 
acridine229,233 derivatives, usually with polynucleotides or short oligonucleotides. 
Although 19F NMR can be used to investigate small molecule-nucleic acid complexes in 
a detailed manner, it also has great potential to identify novel small molecules in 
biologically relevant nucleic acid targets. 19F NMR spectroscopy has been recognized as 
a valuable tool in drug development in the protein field, and 19F NMR based methods 
for Kd determination and small molecule screening are well established.4,11,239-241 
Fluorine is extensively employed to modulate the pharmacological properties of drugs, 
and thus, fluorine is not introduced into small molecules only for detection purposes.44 
Despite 19F NMR-based methods being extensively used in protein-based drug 
discovery, few corresponding studies with nucleic acids have been conducted. The basic 
principles of small molecular ligand-RNA screening are presented below. 
As discussed earlier, internal fluorine probes can be used to investigate small molecule-
nucleic acid interactions. A general concept of this method has been demonstrated by 
investigating the binding of both high-affinity and low-affinity ligands to 2´-F-labelled 
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tobramycin and flavine mononucleotide (FMN) aptamers.17 The changes to the 19F 
signals upon the consecutive addition of ligands were characteristic of the strength of 
the ligand-RNA interactions. In other words, the binding of high-affinity ligands 
occurred in a slow exchange regime, whereas the binding of low-affinity ligands 
occurred in a fast exchange regime. It was additionally demonstrated that the method is 
suitable for larger RNAs. The 53 nt RNA construct contained the ligand binding sites 
for tobramycin and FMN, and binding of these ligands could be detected simultaneously 
(Figure 29). Apparently, this concept has not been used to identify novel small molecules 
binding to biologically relevant targets. 
 
Figure 29. RNA construct (53 nt) bearing ligand binding sites for tobramycin (i.e., hairpin loop 
containing 2´-F adenosine (red)) and FMN (i.e., internal loop containing 2´-F uridine (blue)). 19F 
NMR spectra upon the addition of tobramycin and FMN. Reprinted and modified with permission 
from Kreutz, C.; Kählig, H.; Konrat, R.; Micura, R. Angew. Chem. Int. Ed. 2006, 45, 3450-3453. 
© 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.17 
In an alternative approach, the small molecule contains a fluorine.4,11,239 This approach 
can be further divided into a ligand-based binding (direct ligand observation) and a 
competition ligand-based binding (a reporter displacement method) (Figure 30). In the 
ligand-based binding experiment, the ligand of interest contains fluorine and its binding 
to a nucleic acid target is monitored directly from its fluorine signal. The competition 
ligand-based binding experiment requires a fluorine-labelled molecule, called a spy or 
reporter molecule, which has a weak to medium affinity to a nucleic acid target. A non-
fluorinated ligand of interest displaces the spy molecule from the target, and the binding 
of the ligand can be observed via the fluorine signal of the spy molecule.  
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Figure 30. Schematic presentation of (a) a ligand-based binding and (b) a competition ligand- 
based binding. 
In a recent study, 19F NMR-based fragment screening was applied for the first time to a 
nucleic acid target.40 The target is a telomeric repeat RNA (TERRA) that folds into G-
quadruplexes and is considered to be a potential anticancer target. A library of 355 
chemically and structurally diverse fluorinated fragments was screened against 
TERRA16 (composed of 16 r(UUAGGG) repeats). Fragments that bind to TERRA16 
were identified by comparing 19F spectra in the absence and in the presence of TERRA16. 
An increase in linewidth and a decrease in the intensity of the 19F signal was detected 
upon binding, whereas the 19F signal of nonbinding compound remained unaffected 
(Figure 31a). Using this technique, 20 primary hits were identified, and the binding 
properties of seven of these were further evaluated. The same 19F NMR technique was 
employed to investigate whether these seven hits bind to tRNAPhe; 1H NMR spectroscopy 
was used to investigate whether they bind to a shorter TERRA2 construct (Figure 31b) 
or a DNA analogue of TERRA2 or dsDNA. This selectivity validation showed that some 
of the compounds were selective for G-quadruplexes and, interestingly, favoured the 
parallel propeller-like conformation. Apparently, this is the only research that has 
utilized 19F NMR-based fragment screening of a nucleic acid target. 
 
Figure 31. (a) Schematic presentation of the 19F NMR based screening method. (b) Structures of 
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The spy-molecule approach has been demonstrated by investigating aminoglycoside 
binding into a 16S rRNA A-site model (Figure 32a).52 (Aminoglycosides are antibiotics 
that function by binding in the bulge region of the 16S rRNA A site.243) ()-4-
Fluorocyclopentane-1,3-diamine, which has also been employed as an external structural 
probe (Section 1.3), and a fluorinated paromamine derivative were used as spy molecules 
(Figure 32b).52 Although the binding of aminoglycosides (Figure 32c) could be 
monitored with ()-4-fluorocyclopentane-1,3-diamine (Kd 2 mM), the obtained Kd 
values for high- and low-affinity aminoglycosides were comparable. Therefore, the 
fluorinated paromamine derivative was employed to rank high-affinity aminoglycosides, 
but due to its higher binding affinity, it was unsuitable as a spy molecule using the same 
measurement conditions as ()-4-fluorocyclopentane-1,3-diamine. However, by 
increasing the salt concentration, the binding affinity of the fluorinated paromamine 
derivative decreased (Kd 300 µM vs. 1.1 mM), and its interaction with the target was 
shifted from a slow exchange intermediate to a fast exchange regime. Consequently, in 
these conditions, it was possible to use it as a spy molecule, and it reflected the binding 
strengths of aminoglycosides better than ()-4-fluorocyclopentane-1,3-diamine. This 
research clearly demonstrated that the spy molecule approach can be used to identify 
both high- and low-affinity molecules in a nucleic acid target, but apparently this method 
has not yet been applied to the discovery of novel RNA or DNA binders. 
 
Figure 32. (a) Structure of 16S rRNA A-site model. Binding site of aminoglycosides is circled. 
(b) Structures of spy molecules and (c) investigated aminoglycosides. 
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2. AIMS OF THE THESIS 
Nucleic acids are complex dynamic molecules that may adopt a variety of secondary 
structures. The structural complexity, conformational flexibility, and dynamic and 
adaptive nature of nucleic acid ligand interactions make them challenging biopolymers 
to investigate. 19F NMR spectroscopy has shown its potential to investigate diverse 
nucleic acid structures. Like other spin label-based techniques, 19F NMR spectroscopy 
may be used to provide quantitative information and detailed real-time information about 
structural equilibria and ligand-nucleic acid interactions. As the interest of 19F NMR 
spectroscopy for the detection of nucleic acids has increased, there is increasing demand 
for novel 19F-labelled nucleoside analogues with improved 19F spectroscopic properties. 
Other properties would also be desirable for these analogues such as facile incorporation 
into oligonucleotides, stability of the analogue in a variety of conditions and a non-
invasive nature. The main aim of this thesis was to develop novel 19F-labelled building 
blocks that can be used to characterize DNA and RNA secondary structures. In the 
present study, fluorine-containing reporter groups were introduced into the sugar part. 
Compared to base modifications, the sugar part provides a uniform modification site. 
Thus, the modification can readily be expanded to all four conventional nucleosides, 
allowing labelling at any site of the target oligonucleotide. On the downside, sugar 
modifications can affect the sugar pucker, causing deviations to the overall conformation 
and decreasing the stability of the nucleic acid structures. Modification at the 2´-site may 
also disturb interactions that are related to the 2´-hydroxyl group of the RNA. As the 
purpose was to apply conventional solid-phase oligonucleotide synthesis for the 
incorporation of fluorine labels site-specifically into oligonucleotides, phosphoramidite 
building blocks of fluorinated nucleosides were prepared. The influence of the analogues 
on the stability and conformation of the native oligonucleotide structures were studied 
by distinct methods (UV- and CD-melting profiles and 1H NMR of imino protons), and 
then the applicability of the sensors for the 19F NMR-based detection of the secondary 
structural transitions of the oligonucleotides was evaluated. DNA- and RNA-
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The aims of this thesis may be summarized as follows: 
 To synthesize novel non-invasive fluorinated building blocks that can be 
efficiently incorporated into oligonucleotides by an automated solid-phase 
synthesis (I-III) 
 To evaluate the applicability of these building blocks to characterize DNA and 
RNA secondary structures (including DNA (I) and RNA triplexes (II), RNA 
invasion (I) and RNA hairpin-G-quadruplex equilibria (III)) by 19F NMR 
spectroscopy 
 To provide new information about higher-order secondary structures of 
oligonucleotides, more specifically, triple-helical DNAs and RNAs and 
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3. RESULTS AND DISCUSSION 
3.1 Fluorine-labelled building blocks 
The 19F-labelled nucleoside and non-nucleoside derivatives that have been introduced 
into nucleic acids to characterize RNA and DNA secondary structures were presented in 
Section 1.2.1. Although they have been successfully applied to investigate nucleic acid 
structures, several shortcomings have been described, such as synthetic challenges with 
building blocks, compatibility with oligonucleotide synthesis methods, the general 
stability of the label, changes in the stability and/or structure of the nucleic acid, poor 
shift discrimination, possible sensitivity limitations with a single fluorine atom and the 
need for proton decoupling techniques. The 19F-modified thymidine analogues are all C5 
position modified pyrimidines (Figure 2, Section 1.2.1.1)19,55,100,101,106,111,128,130, and 
several of them bear sterically demanding reporter groups that will likely affect major 
groove mediated interactions. The two sugar modifications, 2´-F17,82,142 and 
2´-SCF394,107,143 presented in Section 1.2.1.2 have been used to investigate RNA 
structures and are not generally compatible with B-form DNA. In fact, sugar-modified 
fluorine probes have not yet been generally applied to characterize DNA secondary 
structures. Although 2´-F is sterically non-perturbing125 and prefers the C3´-endo 
conformation147-150, it bears only one fluorine atom coupled to protons142. 2´-SCF3-
modified ribonucleosides are more sensitive, but the strong preference for C2´-endo 
pucker has restricted the utility of these analogues in single-stranded RNA 
regions.94,107,143 Fluorine-modified nucleobases for RNA bear only one fluorine 
atom21,111, although 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-
2´-deoxyuridine has been employed as an RNA environment as well24,89. The 
incompatibility of 2-fluoroadenosine for solid-phase oligonucleotide synthesis139,140 also 
narrows the repertoire of available purine analogues for site-specific labelling. The 
utility of 5´-end fluorine modifications18,37,53,102 (Section 1.2.1.3) is generally narrow for 
diverse structural studies. Overall, the choices of 19F-modified derivatives in place of 
ribonucleosides are still rather limited, and studies have mainly relied on 
5-fluoropyrimidines. For these reasons, there is demand for novel and improved 
labelling strategies. The fluorine-labelled building blocks presented in this thesis were 
developed from these aspects and are intended to improve or overcome weaknesses 
described above and thus provide viable alternatives to the currently available building 
blocks. 
The fluorine-labelled building blocks (1–6) developed in this thesis are shown in 
Figure 33. 4´-C-[(4-Trifluoromethyl-1H-1,2,3-triazol-1-yl)methyl]thymidine (1)I is 
designed for the detection of DNA secondary structures, whereas 
4´-C-[4-(trifluoromethyl)phenyl]uridine (2)II and 2´-O-(4-trifluoromethyl-1H-1,2,3-
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triazol-1-yl)methyl ribonucleosides (3–6)II,III are designed for the detection of RNA 
secondary structures. Each of the building blocks was incorporated into oligonucleotides 
as phosphoramidite. To obtain the fluorine signals directly as singlets without the need 
for fluorine-proton decoupling and to improve the sensitivity, the reporter groups, i.e., 
(4-trifluoromethyl-1H-1,2,3-triazol-1-yl)methyl and 4-(trifluoromethyl)phenyl, contain 
a trifluoromethyl (CF3) group in a quasi-isolated spin system. The triazoyl moiety was 
synthetically easily accessible. It is a weak base244 and is uncharged in the pH range used 
in 19F NMR measurements (i.e., pH 5.5–7.0).  
 
Figure 33. Synthesized fluorine-labelled building blocks. 
It has been shown that the 4´-C-modifications face the minor groove in double-helical 
DNA and usually induce only minor changes to the stability of the double helix.245-254 
Therefore, it was expected that introducing 1 into the DNA may be a non-disturbing 
substitution but one that is sensitive to secondary structural rearrangements. In addition, 
the nucleoside of 1 predominantly has an S-type conformation typically adopted in B-
type duplexes (Section 3.1.3). The applicability of 1 as a non-invasive derivative for 19F 
NMR studies was demonstrated with DNA triplexes (Section 3.2.2).I On an RNA duplex 
4´-C-modifications orient outward from the helix. Therefore, a modest sensitivity to 
structural rearrangements was expected for 4´-C-reporter groups in an RNA environment 
upon hybridization. Despite this possible shortcoming, a 4´-C-modified building block 
2 was synthesized.II As an advantage over the other labelled building blocks, it bears a 
free 2´-OH group. However, its 19F NMR properties were found to be disadvantageous. 
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Its properties compared to 1 and 3 are presented in Section 3.3.2. Whilst 1 is designed 
for a DNA environment (due to the orientation of the reporter group, the lack of a 2´-OH 
group and the preference for an S-type conformation, as discussed above), its 
applicability in an RNA environment was demonstrated as well (Section 3.3.1).I Similar 
to other 2´-modifications, the possible shortcomings of 2´-O-(4-CF3-1H-1,2,3-triazol-
1-yl)methyl modifications may arise from sugar puckering and the disturbance of 2´-OH 
related interactions. The sugar conformation analysis of the nucleoside of 3 showed the 
preferred N conformation that is desired in RNA (Section 3.1.3). It was also shown to be 
a non-invasive substitution in RNA triplexes (Section 3.4).II Due to these promising 
results, 2´-O-(4-CF3-1H-1,2,3-triazol-1-yl)methyl modification was incorporated into 
cytidine and purine nucleosides as well. These 19F-labelled building blocks (4–6) were 
used to characterize bistable hairpin-G-quadruplex structures (Section 3.5).III 




The synthesis of 4´-C-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]thymidine phosphoramidite 
(12) is outlined in Scheme 1.I The multistep synthesis of 4´-C-azidomethyl-
5´-O-(4,4´-dimethoxytrityl)thymidine (10) starting from thymidine (7) has previously 
been described.253,255,256 Accordingly, 3´-O-(4,4´-dimethoxytrityl) (DMTr) -protected 
4´-C-hydroxymethylthymidine (8) was first synthesized from thymidine (7), and the 
primary hydroxyl groups of 8 were then converted to trifluoromethanesulfonyl (Tf) 
groups. The obtained triflate nucleoside was cyclized into an O2,5´-anhydronucleoside257, 
and the remaining Tf-group was replaced with an azide ion to obtain 9. The hydrolysis 
of the anhydronucleoside linkage, exposure of the 3´-OH group, and DMTr-protection 
of the 5´-OH group provided 10 in 49 % overall yield from 7. The copper(I)-catalyzed 
azide-alkyne cycloaddition258,259 between the 4´-C-azidomethyl group and gaseous 
3,3,3-trifluoropropyne in the presence of sodium ascorbate afforded 11 bearing a 
(4-CF3-1H-1,2,3-triazoyl)methyl group. Compound 11 was then quantitatively 
phosphitylated to the phosphoramidite 12.  
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Scheme 1. Synthesis of phosphoramidite building block 12. Conditions: 
i) 3,3,3-trifluoroprop-1-yne, CuSO4, sodium ascorbate, H2O, DMSO ii) 2-cyanoethyl 
N,N-diisopropylchlorophosphoramidite, Et3N, DCM. 
3.1.1.2 4´-C-[4-(Trifluoromethyl)phenyl]uridine phosphoramidite  
The synthesis of the 4´-C-[4-(trifluoromethyl)phenyl]uridine phosphoramidite building 
block (22) is depicted in Scheme 2.II The starting compound 13 could be synthesized 
from ribose on the multigram scale following a previously published method.260 A 
Grignard reaction between 4-(trifluoromethyl)phenylmagnesiumbromide and ketone 13 
stereoselectively gave 14 (73% yield, 2R:2S, 7:1, n/n). The tert-butyldimethylsilyl group 
(TBDMS) was then replaced by a benzoyl group (Bz) (15) to avoid premature pyranose 
formation during the subsequent steps. The oxidation of the alkene with OsO4 followed 
by periodic acid treatment provided 16. The isopropylidene group was then removed, 
and the deprotected hydroxyl groups were protected with Bz-groups (17). The 
N-glycosidation of 17 gave 18 in 72% yield. The β-anomer was the major product due 
to the neighbouring group participation via the 2´-O-Bz group. The 2D NOESY 
correlation between the H1´ and aromatic protons of 4-(trifluoromethyl)phenyl (CF3Ph) 
verified the 4´R-configuration. The major problem of the synthesis was the 
4,4´-dimethoxytritylation of the 5´-OH group of 19 (20 in 40% yield). The reactivity of 
the 5´-OH group was comparable to that of the 2´-OH group due to the steric hindrance 
of the 4´-CF3Ph group, and therefore a substantial amount of the 2´,5´-bistritylated 
derivative was formed together with the desired product (20). Several synthetic 
approaches were attempted to overcome this problem (Experimental Section). For 
example, the 5´-O-Bz group of 18 was removed selectively by [tBuSnOHCl]2 in 
methanol261, the exposed 5´-OH group was tritylated and the 2´-O- and 3´-O-Bz 
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protections were removed by NaOMe treatment. By this strategy, the yield was slightly 
improved (51%). However, the direct tritylation of 19 proved to be a less complex 
method. Moreover, 19 could be readily recovered from the bistritylated sideproduct. 
Finally, the 2´-OH was protected with a triisopropylsilyloxymethyl group (TOM) (21) 
and the 3´-OH group was phosphitylated to give phosphoramidite 22. The overall yield 
from 13 to 22 was 6 %. Instead of the TOM group, the TBDMS group was initially used 
for protecting the 2´-OH group. However, both the synthesis of the corresponding 
2´-O-TBDMS protected phosphoramidite and its introduction into oligoribonucleotides 
were difficult (Experimental Section). 
 
Scheme 2. (i) 4-Bromobenzotrifluoride, Mg, Et2O; (ii) TBAF, THF; (iii) BzCl, DMAP, Py; (iv) 
1: OsO4, 4-methylmorpholine N-oxide, acetone; 2: H5IO6, THF; (v) HCl, H2O, dioxane; (vi) 
TMSOTf, 2,4-bis(trimethylsilyloxy)uridine, MeCN; (vii) NaOMe, MeOH; (viii) DMTrCl, Py; 
(ix) [tBuSnOHCl]2, MeOH; (x) DIEA, Bu2SnCl2, (triisopropylsiloxy)methyl chloride, 
1.2-dichloroethane; (xi) 2-cyanoethyl N,N-diisopropylchlorophosphoramidite, Et3N, DCM. 
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3.1.1.3 2´-O-(4-Trifluoromethyl-1H-1,2,3-triazol-1-yl)methyl modified 
phosphoramidites 
The syntheses of 2´-O-(4-CF3-1H-1,2,3-triazol-1-yl)methyl modified phosphoramidite 
building blocks are outlined in Scheme 3.II,III A straightforward synthesis of 
2-´O-(azidomethyl)-5´-O-(4,4´-dimethoxytrityl)ribonucleosides (27a-d) from 
commercially available 3´,5´-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-protected 
ribonucleosides (23a-d) bearing appropriate base protections has previously been 
reported.262-264 Accordingly, 23a-d were treated with a mixture of dimethyl sulfoxide 
(DMSO), acetic anhydride (Ac2O) and acetic acid (AcOH).262 The 3´,5´-cyclic silyl 
protecting groups were then removed with tetrabutylammonium fluoride (TBAF) to 
obtain 24a-d. The 2´-O-methylthiomethyl groups were converted to 2´-O-chloromethyl 
intermediates 25a-d by 2-nitrobenzenesulfenyl chloride (NBSCl), and subsequent 
treatment with NaN3 gave 2´-O-azidomethyl derivatives 26a-d.263,264 In the case of 
purine derivatives, NBSCl was added in the presence of trifluoromethanesulfonic acid 
to prevent a side reaction between the 2´-O-chloromethyl intermediate and the N3 of a 
purine nucleobase to give a cyclonucleoside.263The 5´-OH groups were protected with 
DMTr group (27a-d). The 2´-O-azidomethyl groups were then exposed to copper(I)-
catalyzed azide-alkyne cycloaddition with gaseous 3,3,3-trifluoropropyne to give 28a-d. 
Finally, compounds 28a-d were converted to the corresponding phosphoramidites 29a-d 
using 2-cyanoethyl N,N-diisopropylchlorophosphoramidite. The overall yields were 
64-80 % (calculated from azides 27a-d).  
 
Scheme 3. (i) DMSO, Ac2O, AcOH; (ii) TBAF, THF; (iii) NBSCl, DMF (CF3SO3H); (iv) NaN3, 
DMF; (v) DMTrCl, Py; (vi) 3,3,3-trifluoroprop-1-yne, CuSO4, sodium ascorbate, H2O, DMSO; 
(vii) 2-cyanoethyl N,N-diisopropylchlorophosphoramidite, Et3N, DCM. 
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3.1.2 Synthesis of fluorine-labelled oligonucleotides 
Fluorine-labelled oligonucleotides were synthesized on the 1.0 µM scale using an 
automatic DNA/RNA synthesizer applying standard phosphoramidite coupling 
chemistry. Benzylthiotetrazole (BnSTet) was used as an activator. Coupling times of 
20 s and 300 s were used for the standard commercially available DNA and RNA 
phosphoramidite building blocks, respectively. 19F-labelled phosphoramidites 29a-c 
were incorporated into oligonucleotides as an integral part of the automatic synthesis by 
increasing the coupling time to 600 s (no other adjustments were made to the standard 
coupling cycles). The coupling yields of 29a-c were comparable to those of 
commercially available phosphoramidite building blocks (> 98 %) according to a trityl 
assay. 29d was manually coupled due to its low solubility in acetonitrile. Accordingly, 
a solution of 29d (0.20 mol L-1 in dry acetonitrile, 200 µL, 40 µmol) was mixed with a 
BnSTet solution (0.25 mol L-1, in dry acetonitrile, 160 µL, 40 µmol). The opaque 
solution of 29d cleared up after the addition of BnSTet. This mixture was suspended 
with a CPG (controlled pore glass) support bearing 1 µmol of the sequence before 29d 
and mixed for 10 min under nitrogen. The mixture was then loaded back onto the 
synthesis column and filtered. Capping (with a mixture of Ac2O, lutidine and 
N-methylimidazole in tetrahydrofurane (THF), 5:5:8:82, v/v/v/v) and oxidation (with a 
mixture of 0.02 mol L-1 I2 in pyridine (Py) and H2O in THF 1:21:213, v/v/v) steps were 
performed manually followed by washings with acetonitrile. The column was then 
coupled to the synthesizer, and the automatic chain elongation was continued. According 
to the trityl assay, 29d coupled nearly quantitatively (> 98 %). Also, for 12 and 22, better 
coupling efficiencies (12: 98% and 22: 90%) were achieved by applying manual 
coupling, but smaller excesses of 12 and 22 could be used (10 equiv). It is worth noting 
that the 2´-O-TBDMS-protected 4´-C-[4-(trifluoromethyl)phenyl]uridine 
phosphoramidite (36, Experimental Section) coupled inefficiently (coupling yield 
~20%) due to the steric hindrance of the TBDMS group.  The oligonucleotides were 
released from the support and deprotected by standard ammonolysis 
(2´-deoxyoligonucleotides in concentrated ammonia at 55 ºC overnight, 
oligoribonucleotides in a mixture of concentrated ammonia and ethanol 3:1, v/v, 3.5 h at 
55 ºC and overnight at rt). The 2´-O-TBDMS and 2´-O-TOM -protections were removed 
by a standard protocol with triethylamine trihydrofluoride treatment followed by 
cartridge filtration to remove traces of reagents and protecting groups. The crude 
oligonucleotides were purified with reverse-phase high-performance liquid 
chromatography (RP HPLC) using a semipreparative column at either ambient 
temperature or elevated temperature (60 °C) (Figure 34). The homogeneity of the 
oligonucleotides was confirmed by RP HPLC, and the authenticity was verified by 
electrospray ionization time-of-flight mass spectrometry (ESI-TOF MS).  
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Figure 34. A representative example of the RP HPLC trace of a crude oligoribonucleotide 
containing a 2´-O-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]uridine (3) (ON13, Figure 43). 
Conditions: a semipreparative RP HPLC column (C-18, 250 × 10 mm, 5 μm), a gradient elution 
of 0–50% acetonitrile in 0.1 mol L-1 triethylammonium acetate in 25 min at 25 °C, flow rate 
3.0 ml min-1, detection at 260 nm. MS (ESI-TOF) spectra of the purified oligoribonucleotide 
(ON13).  
3.1.3 Sugar conformation of the fluorinated nucleosides 
Substituents can affect the sugar ring conformation and hence significantly decrease the 
stability of the nucleic acids. The sugars in B-type dsDNA prefer the C2´-endo 
conformation (S-type), whereas those in A-type dsRNA prefer the C3´-endo 
conformation (N-type).146 The sugar pucker preference can, however, vary from those 
observed in canonical dsDNA and dsRNA, particularly in single-stranded and non-
canonical regions.107,143,146,193 The sugar puckers of the corresponding nucleosides of 1, 
2 and 3 (i.e., 30I, 31II and 32II, Figure 35a) were determined using the optimized Karplus 
relation for 1H NMR H1´-H2´ coupling constants (JH1´-H2´)265. 4´-C-[(4-CF3-1H-1,2,3-
triazol-1-yl)methyl]thymidine (30, Figure 35b) favoured the DNA-type C2´-endo 
conformation (S 72%, JH1´-H2  ́ = 7.3 Hz), and 2´-O-[(4-CF3-1H-1,2,3-triazol-1-
yl)methyl]uridine (31, Figure 35c) existed predominantly as an RNA-type C3´-endo 
conformation (N 67%, JH1´-H2  ́= 3.3 Hz). The population of the C3´-endo conformation 
for 4´-C-[4-(trifluoromethyl)phenyl]uridine (32) was N 48% (JH1´-H2  ́= 5.3 Hz) and the 
corresponding value for uridine was N 53% (JH1´-H2  ́= 4.8 Hz). The sugar 
conformation of 3 was additionally determined in a short single-stranded RNA sequence, 
5´-AU3A-3´. The obtained C3´-endo population of 3 in this sequence was N 32% 
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(JH1´−H2´ = 6.9 Hz), and the corresponding values (N %) for the other residues were 48% 
(JH1´−H2  ́= 5.3 Hz, A), 50% (JH1´−H2´ = 5.1 Hz, A) and 46% (JH1´−H2´ = 5.5 Hz, U). In the 
non-labelled sequence, 5´-AUUA-3´, the corresponding values (N %) were 50% 
(JH1´−H2  ́= 5.1 Hz, A), 46% (JH1´−H2´ = 5.5 Hz, A), 44% (JH1´−H2´ = 5.7 Hz, U) and 46% 
(JH1´−H2  ́ = 5.5 Hz, U). It may be worth noting that 2´-O-[(4-CF3-1H-1,2,3-triazol-1-
yl)methyl]uridine (3) hence existed as relatively low C3´-endo populations (N 32%) in 
this short RNA single strand, but so did the unmodified ribonucleotides (N 44–50%).   
 
Figure 35. Sugar puckering. (a) Structures and sugar pucker of fluorine-labelled nucleosides and 
uridine. (b) Sugar puckering of 4´-C-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]thymidine (30) and 1H 
NMR and NOESY spectra used for analysis. (c) Sugar puckering of 2´-O-[(4-CF3-1H-1,2,3-
triazol-1-yl)methyl]uridine (31) and 1H NMR used for analysis. 1H NMR (500 MHz) 
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3.2  DNA triplexes 
3.2.1 Introduction to triple helices 
Both artificial triplex-forming oligonucleotides (TFOs) and naturally occurring triple 
helices have been investigated intensively for decades. TFOs have gained enormous 
attention as potential therapeutic agents, because they can bind sequence-specifically to 
genomic DNA and affect gene expression (i.e., antigene strategy).266,267 In general, TFOs 
can be used as tools to site-specifically manipulate DNA, and a variety of biological 
applications have been described.266-270 For instance, TFOs have been used to inhibit 
transcription and replication and to induce mutations and recombination. Naturally 
occurring DNA triplexes (H-DNAs) may be involved in gene expression 
regulation.269,271-273 H-DNAs induce genetic instability, and have been associated with 
several diseases269,274,275 such as Friedreich’s ataxia276, autosomal dominant polycystic 
kidney disease and lymphomas269. In contrast to DNA triplexes, RNA triplexes have 
attracted little attention, but their biological importance has recently been recognized 
(Section 3.4).273,277,278 As TFO-based targeting has heavily focused on DNA, it may also 
be worth noting that the targeting of the double-helical regions of RNA by TFPNAs has 
shown promising results.95,279,280 In addition, accumulating evidence suggests that some 
noncoding RNA (ncRNA, non-protein coding RNA) regulatory mechanisms are 
mediated through triplex formation with genomic DNA.273,278,281-285 Overall, triple-
helical nucleic acids are a diverse, constantly emerging multidisciplinary research area.  
Various methods are used to investigate triplexes: for example, UV75 and CD76,77 
spectroscopy, fluorescence based techniques286,287, isothermal titration calorimetry 
(ITC)187, gel electrophoresis184,288 and NMR183,289,290. Among the used methods, the UV 
melting study75 is probably the most used technique. However, this technique has several 
limitations that can complicate the interpretation of the melting profile such as 
overlapping or wide melting transitions and small absorbance changes. In addition, 
intermediate structures or coexisting species are difficult or impossible to detect and 
analyse. As UV spectroscopy does not provide structural information, it is often used in 
combination with CD spectroscopy. Although CD spectroscopy can be used to 
characterize triplexes76,77, it has rather similar caveats to those of UV spectroscopy for 
analysing intermediate structures, coexisting species or large nucleic acids. Although 
several methods are available, the interest in 19F NMR to investigate triplexes arises from 
its ability to probe structural species in a quantitative manner in different surrounding 
conditions. A deeper understanding of the conformational transitions of triple helical 
oligonucleotides may increase the medicinal potential of these complex secondary 
structures. In this thesis, the 19F NMR spectroscopic detection of both DNAI and RNAII 
triplexes has been investigated, and new information could be provided. 
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Nucleic acids can form both intra- (i.e., the triple helical structure is formed within a 
nucleic acid molecule) and intermolecular (i.e., the triple helical structure is formed 
between distinct nucleic acid molecules) triple helical structures.182-184 In a triple helical 
structure, a single-stranded third strand is bound sequence-specifically to the major 
groove of a polypurine-polypyrimidine duplex. The third strand can be oriented either 
parallel or antiparallel relative to the polypurine strand of the duplex. The investigated 
DNA (Section 3.2.2) and RNA triplexes (Section 3.4) in this thesis are parallel 
pyrimidine motif triplexes, and antiparallel triplexes are not discussed. In the parallel 
pyrimidine motif triplexes, T/U•A-T/U and C+•G-C base triplets (• Hoogsteen base 
pairing, - Watson-Crick base pairing, C+ a N3-protonated cytosine) are formed via 
Hoogsteen hydrogen bonding (Figure 36).182-184 Several factors influence the formation 
kinetics and stability of the triplex, such as the sequence length, base and backbone 
composition, pH, salt concentration and temperature.184,186,187,291-293 The stability of 
C-rich pyrimidine motif triplexes is strongly dependent on pH, because the C+•G-C base 
triplet requires a N3-protonated cytosine (pKa value for N3 of cytidine is 4.2126).185-189 
Therefore, the formation of C-rich triplexes is typically favoured in acidic conditions, 
which limits their occurrence in physiological conditions. Under acidic conditions, 
C-rich sequences can also form competitive structures such as CC+-duplexes and 
i-motifs that disturb the triplex formation.190,191 In addition, ligands can affect the 
formation and stability of triplexes.294,295 For example, neomycin (an aminoglycoside 
antibiotic, Figure 36) has been shown to significantly stabilize triplexes.296-305 
 
Figure 36. Schematic presentation of parallel pyrimidine motif triplex ( Hoogsteen hydrogen 
bonding, - Watson-Crick base pairing). T/U•A-T/U and C+•G-C base triplets. Structure of a 
parallel pyrimidine motif DNA triplex (PDB ID 1BWG290). Neomycin binds in the triplex major 
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Several factors limit the efficient triplex targeting and formation in physiological 
conditions, for example, pH- and cation-dependency, charge and steric repulsion, kinetic 
properties, self-associated structures, thermal stability, base triplet code, modest affinity, 
cellular delivery and stability to intracellular nucleases.266,267,269,294,306,307 Therefore, a 
considerable number of chemical modifications and conjugate groups have been 
introduced into TFOs to improve their properties.266,267,294,306-308 Publication IV describes 
the syntheses and hybridization properties of triplex-forming aminoglycoside 
2´-O-methyl oligoribonucleotide conjugates in which aminoglycoside modifications 
have been incorporated into desired positions of oligonucleotide chains as 
phosphoramidite building blocks. However, as it is not related to 19F NMR spectroscopy, 
it is not discussed in this thesis, even though it is included in the PhD studies of the 
author. 
3.2.2  Characterization of DNA triplexes 
DNA triplexes were investigated using 4´-C-[(4-CF3-1H-1,2,3-triazol-
1-yl)methyl]thymidine (1).I As discussed, due to the orientation of the reporter group 
and the S-type sugar conformation, it was expected that 1 is a sensitive non-invasive 
derivative in DNA environments. The triplex structure chosen for the studies is the same 
pH-dependent parallel pyrimidine motif triplex ON1/ON4/ON5 (Figure 37) that was 
previously investigated by Tanabe et al.35 using 2´-deoxy-5-fluorouridine (Section 
1.2.2.7). They had incorporated the label in the third strand and showed that it was able 
to detect triplex formation. In addition, they monitored the pH- and temperature-
dependent behaviour of the triplex-forming strand. Similarly to this previous study, 1 
was positioned at the middle of a pyrimidine strand (ON1). ON1 is the third strand in 
the ON1/ON4/ON5 triplex (i.e., paired via the Hoogsteen face) (Figure 37). To also 
monitor the behaviour of the underlying duplex, an ON1/ON2/ON3 triplex in which the 
ON1 is the pyrimidine strand of the duplex (i.e., paired via the Watson-Crick face) was 
investigated as well (Figure 37). Tanabe et al.35 did not report whether 2´-deoxy-
5-fluorouridine can be used to distinguish triplex and duplex structures when positioned 
in a Watson-Crick strand. 
The influence of 1 on the thermal stability of the structures was investigated by UV 
spectroscopy. As seen in Table 2, 1 had a minor effect on the stability. The CD-profiles 
additionally confirmed that the labelled sequences formed triplex structures similarly to 
their native counterparts. 
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Figure 37. 19F NMR signals of labelled probe in different DNA-hybridization modes. Conditions: 
i) 100 μmol L-1 of ON1, 10 mmol L-1 sodium phosphate (pH = 5.5) 2 mmol L-1 Mg2Cl and 
0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v) at 25 ºC, ii) the same as i), but pH = 6.0 at 37 ºC, 
iii) 50 μmol L-1 of ON1, 45 μmol L-1 ON2, 10 mmol L-1 sodium phosphate (pH = 6.0) 
2 mmol L-1 Mg2Cl and 0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v) at 37 ºC, iv) 50 μmol L-1 of ON1, 
50 μmol L-1 ON2, 50 μmol L-1 ON3, 10 mmol L-1 sodium phosphate (pH = 6.0) 2 mmol L-1 Mg2Cl 
and 0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v) at 50 ºC, the passive temperature-dependent shift has 
been eliminated and the shifts have been interpolated to those at 37 ºC, v) 100 μmol L-1 of ON1, 
100 μmol L-1 ON3, 100 μmol L-1 ON4, 10 mmol L-1 sodium phosphate (pH = 6.0) 2 mmol L-1 
Mg2Cl, 0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v) at 37 ºC. (Note: in spite of the virtual homogeneity 
of the oligonucleotides, the shoulders of the 19F NMR signals most likely originate from 
impurities). 
19F NMR studies were then carried out (detailed measurement conditions are presented 
in the caption of Figure 37). As seen in Figure 37ii, ON1 at pH 6.0 gave a sharp signal 
at -62.53 ppm that corresponds to the single strand, whereas at pH 5.5 (Figure 37i), a 
broad signal at ~ 0.6 ppm upfield was additionally detected, attributed to unspecific 
C-CH+ interactions. This pH-dependent behaviour of ON1 is consistent with that 
described by Tanabe et al.35 Next, the ON1/ON4/ON5 triplex formation was 
investigated by the titration of ON1 with the duplex ON4/ON5. As seen in Figure 38a, 
upon the consecutive addition of ON4/ON5 duplex, a new unique signal appeared 
at -61.69 ppm indicating the formation of ON1/ON4/ON5 triplex. As well-separated 
signals (∆δ = 0.84 ppm) were detected, the temperature-dependent behaviour of the 
ON1/ON4/ON5 triplex was then studied to evaluate the applicability of 1 for melting 
temperature determination. The temperature-dependent 19F NMR spectra are shown in 
Table 2. UV-melting temperatures (Tm/ºC) of the 1-modified secondary structures 
entry oligonucleotides Tm/ºC (∆Tm/°C) 
1 ON1/ON2-duplex 54.9 (-0.6) 
2 ON1/ON2/ON3-triplex 32.9 (-0.6) 
3 ON1/ON4/ON5-triplex 31.0 (-1.7) 
ΔTm in comparison to those obtained with unmodified oligonucleotides (X = thymidine). Conditions: 
10 mmol L-1 NaH2PO4 (pH = 6.0), 0.1 mol L-1 NaCl, 2.0 mmol L-1 MgCl and 2.0 μmol L-1 of each 
oligonucleotide. UV-detection at 260 nm. 
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Figure 38b. When the molar fraction of ON1 was plotted against the temperature (Figure 
38c), a sigmoidal curve resulted. The Tm value could be extracted from the inflection 
point (66 °C). The obtained Tm value is not comparable to that determined by UV 
spectroscopy (31 °C) due to the concentration dependency of the triplex formation 
(100 µmol L-1 vs. 2 µmol L-1).  
Figure 38. (a) DNA-triplex formation and (b and c) its thermal melting followed by 19F NMR 
spectroscopy. Conditions: 100 μmol L-1 ON1 (X = 1), 0-120 μmol L-1 ON4 and ON5 (1:1, n/n), 
10 mmol L-1 sodium phosphate (pH = 6.0), 2 mmol L-1 MgCl and 0.1 mol L-1 NaCl in D2O-H2O 
(1:9, v/v).  
The formation and melting of ON1/ON2/ON3 triplex in which ON1 is paired via the 
Watson-Crick face was investigated in a similar manner. A lower ON concentration 
(50 µmol L-1) was, however, used for the measurements (a seemingly direct conversion 
of ON1/ON2/ON3 triplex to ON1 was observed at a 100 µmol L-1 ON concentration 
due to the concentration dependency of the triplex formation). As seen in Figures 35 iii 
and iv, distinct 19F signals were detected for the duplex (-62.17 ppm) and the triplex 
(-61.86 ppm). Consequently, by this labelling strategy, it was possible to monitor the 
melting of the triplex and the duplex. The molar fractions of the structural species upon 
heating were obtained from the relative peak areas, and the Tm values could be extracted 
from the 19F NMR data (Figure 39). In addition, the denaturation of ON1/ON2/ON3 
triplex was monitored in the presence of neomycin. As seen in Figure 39, a 
stoichiometric amount of neomycin stabilized the triplex (∆Tm = 4 °C) whereas the 
duplex stability remained almost unaffected as expected.  
In conclusion, 1 was proven to be suitable for the characterization of DNA triplexes 
providing well-separated signals for structural species. Compared to the results reported 
by Tanabe et al.35 1 provided clearly sharper signals than 2´-deoxy-5-fluorouridine 
(Figure 18). In addition, the temperature-dependent data obtained using 1 could be used 
to extract Tm values.  
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Figure 39. DNA-triplex/duplex/single strand conversions followed by 19F NMR spectroscopy. 
Conditions: 50 μmol L-1 ON1 (X = 1), ON2 and ON3, 10 mmol L-1 sodium phosphate (pH = 6.0), 
2 mmol L-1 MgCl and 0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v).  
3.3 Comparison of 19F NMR properties 
3.3.1 1 vs 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-
2´-deoxyuridine on a HIV-1 TAR-model 
Our laboratory has previously applied 19F NMR spectroscopy to characterize the 
invasion of 2´-O-methyl oligoribonucleotides into a 19F-labelled HIV-1 TAR model 
(Section 1.2.2.6).24,89 In these previous studies, the 5-[4,4,4-trifluoro-
3,3-bis(trifluoromethyl)but-1-ynyl]-2´-deoxyuridine was positioned in the upper stem of 
the HIV-1 TAR hairpin, and it was able to reflect the denaturation of the hairpin 
(i.e., A/B equilibrium) as well as the melting of the macro-loop complex to the open 
chain invasion complex (i.e., C/D equilibrium) (Figure 40a). Both of these equilibria 
were able to be monitored from separate albeit partly coalescent signals, indicating that 
the equilibria between these intramolecular secondary structures were slow on the NMR 
time scale. As intramolecular hybridizations are usually fast on the NMR time scale, it 
was attributed that the 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-
2´-deoxyuridine itself deviated the equilibrium rate. Therefore, the same TAR model 
was modified with 1, and the invasion studies were repeated.I  
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Three 1-modified HIV-1 TAR models were synthesized in which 1 was positioned at the 
loop (ON6), at the upper stem (ON7) or at the lower stem (ON8) (Figure 40a). The 
labelling site of ON7 was the same as that previously used for 5-[4,4,4-trifluoro-
3,3-bis(trifluoromethyl)but-1-ynyl]-2´-deoxyuridine. As seen in Table 3, the effect of 1 
was either marginal or slightly destabilizing, depending on the substitution site. 
 
The temperature-dependent behaviour of the 19F-labelled HIV-1 TAR models were 
monitored in the presence and absence of 1.0 equivalent of a 12 mer 2´-O-methyl 
oligoribonucleotide (ON9) (Figure 40a). 19F NMR measurements were carried out using 
a 50 µmol L-1 oligonucleotide concentration in a 10 mmol L-1 sodium cacodylate buffer 
containing 0.1 mol L-1 NaCl, pH 7.0, D2O-H2O (1:9, v/v). (Previous conditions: 
20 μmol L-1 19F-labelled HIV-1 TAR with ON9 in 0.1 mol L-1 NaCl with 25 mmol L-1 
sodium phosphate, pH = 6.5, D2O-H2O (1:9, v/v)).24 As seen in Figure 40b, the labels 
positioned into the double-helical regions (ON7 and ON8) allowed the monitoring of 
the hairpin melting (A/B equilibrium). In contrast, the label positioned in the loop region 
(ON6) was insensitive to the melting of the hairpin and shifted continuously (over 
0.5 ppm) over the measured temperature range. The Tm values obtained for ON7 (71 °C) 
and ON8 (68 °C) from 19F NMR data were close to those determined by UV 
spectroscopy (ON7 and ON8 71.0 °C and 69.2 °C, respectively). Compared to the 
previous study, in which the melting occurred in a slow exchange regime24, well-
behaving coalescence signals were now obtained (Figure 41a). By ON8, it was possible 
to monitor the equilibrium between the macro-loop complex and the open chain invasion 
complex (C/D equilibrium). Also here, an averaged 19F signal between the structures 
(C/D) was detected (Figure 41b). The signal was broad indicating that the process was 
slower compared to the melting of the hairpin (A/B equilibrium). A Tm value (39 °C) 
was obtained from the inflection point of the melting profile (Figure 40b). The label 
located in the upper stem of the TAR (ON7) was also able to sense the C/D equilibrium, 
but the obtained shift versus temperature profile was unclear. Although the signals of the 
hairpin (A) and the macro loop complex (C) overlapped (Figure 40b), the titration with 
ON9 could be followed at 55ºC, i.e., under conditions where the hairpin (A) was directly 
converted to the open chain invasion complex (D) (Figure 41c). Finally, the thermal 
denaturation of the open chain invasion complex (B/D equilibrium) could be monitored 
from the relative peak areas using ON6 (Figure 41d). As a result, these studies showed 
that 1 is also an informative relative non-invasive modification in RNA environments, 
Table 3. UV-melting temperatures (Tm/ºC) of the 1-modified HIV-1 TAR models 
entry oligonucleotides Tm/ºC (∆Tm/°C) 
1 ON6  72.4 (+0.5) 
2 ON7 71.0 (-0.9) 
3 ON8 69.2 (-2.7) 
Conditions: 10 mmol L-1 sodium cacodylate (pH = 7.0), 0.1 mol L-1 NaCl, and 2.0 μmol L-1 of each 
oligonucleotide. ΔTm (in parentheses) in comparison to that obtained with unlabelled HIV-1 TAR model. 
UV-detection at 260 nm. 
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despite the expected modest discrimination due to the orientation of the 4´-C 
modification and the preferred C2´-endo conformation (cf. Section 3.1.3). 









 ON6 + 1 ekv ON9
  
ON7
 ON7 + 1 ekv ON9
 ON8
 ON8 + 1 ekv ON9
 
Figure 40. (a) Fluorine-labelled TAR models and schematic presentation of temperature-
dependent behaviour of invasion complex. (b) 19F NMR shift difference versus temperature 
profiles of 19F-labelled HIV-TAR models (the passive temperature-dependent shift reduced). 
Conditions: 50 μmol L-1 19F-labelled HIV-1 TAR (ON6–8) with and without 50 μmol L-1 of ON9, 
10 mmol L-1 sodium cacodylate (pH = 7.0) and 0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v).  
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Figure 41. 19F NMR spectra of 19F-labelled HIV-TAR models and their invasion complexes 
under increasing temperature. Conditions: 50 μmol L-1 labelled HIV-1 TAR model (ON6–ON8) 
with and without 50 μmol L-1 ON9 (titration carried out in c), 10 mmol L-1 sodium cacodylate 
(pH = 7.0) and 0.1 mol L-1 NaCl in D2O-H2O (1:9, v/v). 
In summary, the invasion mechanism could be characterized with 1, and the results were 
consistent with those of previous 19F NMR studies24,89. However, compared to the 
temperature-dependent data obtained with 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)-
but-1-ynyl]-2´-deoxyuridine24, the intramolecular melting transitions (A/B and C/D 
equilibria) now occurred under  a fast exchange regime, as expected for 
intramolecular hybridizations. Thus, these results seem to suggest that a highly modified 
label such as 4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl may misrepresent the 
denaturation rate, although the modification does not significantly destabilize the 
secondary structure (∆Tm -2.7 °C compared to native TAR24). As a limitation, 1 was 
unable to reflect the equilibrium between the hairpin and macro-loop invasion complex 
(A/C equilibrium), while 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-
2´-deoxyuridine provided well-separated signals for these structures. Therefore, it may 
be concluded that 5-[4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl]-
2´-deoxyuridine was more suitable for titration studies, whereas 1 reflected the 
temperature-dependent behaviour of complexes more reliably. 
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3.3.2 1, 2 and 3 on a miR-215 hairpin 
Several studies presented in the Introduction Section (1) are based on the labels’ ability 
to distinguish single- and double-stranded environments. This shift dispersion ability is 
typically used to evaluate novel fluorinated nucleoside analogues for further studies, as 
this property can be readily applied to characterize more complex structures. To evaluate 
and compare the properties of 1–3, they were introduced into a pri-miRNA-215 hairpin 
model309 (ON10–ON12, Figure 42), and their ability to reflect an intramolecular melting 
process was monitored.II UV melting studies did not show differences between the 
derivatives on the thermal stability of the hairpin, and the modifications had only a minor 
effect on the stability of the hairpin (in each case, ΔTm < -1.0 °C compared to the 
unlabelled pri-miRNA-215 hairpin model). The 19F NMR measurements were carried 
out using an RNA concentration of 50 µmol L-1 in a mixture of 0.1 mol L-1 NaCl and 10 
mmol L-1 sodium cacodylate at pH 6.0, D2O–H2O (1:9, v/v). Each of the probes gave a 
coalescence signal that discriminated between the hairpin (E) and denaturated form (F), 
as expected for intramolecular hybridization. As seen in Figure 42, in each case, a 
sigmoidal melting profile was obtained, and comparable Tm values (~ 55 °C) were 
obtained from the inflection points. However, clear differences could be observed in the 
shift dispersion between the single- (F) and double-stranded (E) environment. 
3 provided the largest shift dispersion (Δ = 0.82 ppm, ON12), which is likely related to 
the shielding of the H-5´,5´´ protons of the preceding nucleotide in the helix. The modest 
shift dispersions of 1 (Δ = 0.23 ppm, ON10) and 2 (Δ = 0.12 ppm, ON11) are likely 
related to the orientation of the reporter groups. As discussed, the substituent at the 4´-C 
site orients outward from the RNA helix, and thus the reporter groups probably 
encounter only modest changes in the local environment upon hybridization. The 
applicability of 1 an RNA environment was already demonstrated with HIV-1 TAR 
studies. However, 1 is designed for DNA, and its shift dispersion between the single- 
and double-stranded DNA environments is better than that in RNA. In addition to the 
poor shift response, the synthetic properties of 2 are also disadvantageous: the synthesis 
of the corresponding phosphoramidite of 2 (i.e., 22) was complex, and it coupled with 
lower efficiency. Therefore, no further studies were conducted with 2. In conclusion, 
among these derivatives, 3 seems to be the most promising for RNA studies: it provided 
a large shift dispersion, the synthesis of the corresponding phosphoramidite (i.e., 29a) 
was facile, and it coupled efficiently in the DNA/RNA synthesizer.  
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Figure 42. 19F NMR shift versus temperature profiles and profiles of the shift differences versus 
temperature after the subtraction of a passive temperature-dependent shift (0.014 ppm K-1) 
obtained by 1, 2 and 3 upon the thermal denaturation of a PRI-miR-215 hairpin model (E/F). 
Conditions: 50 µmol L-1 of ON in 0.1 mol L-1 NaCl and 10 mmol L-1 sodium cacodylate at pH 6.0, 
D2O–H2O (1:9, v/v). 
3.4 RNA triplexes 
Similar to DNA, RNA can form parallel pyrimidine motif triplexes via Hoogsteen 
hydrogen bonding (Section 3.2.1, U•A-U and C+•G-C base triplets Figure 36). In fact, 
the first reported triplex was a poly(rU)poly(rA)poly(rU) RNA triplex.310 Although 
triplex interactions are ubiquitous structural motifs in RNA tertiary structures311, the 
biological importance of RNA triplexes has been recognized more recently273,277,278. 
Triplexes have been found to play essential functional roles, for instance, in SAM-II 
riboswitch312, telomerase313,314, spliceosome315 and ribosomal frameshift pseudoknots316. 
Moreover, a triple helix forming RNA structure, called an element for nuclear expression 
(ENE, previously named an expression and nuclear retention element), has been 
recognized to act as a general stability and regulatory element.317-323  
In the present thesis, two triple-helical structures were chosen for 19F NMR experiments: 
one is an artificial model288 and the other is a viral stability and regulatory element called 
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PAN ENE317. Both of these structures were labelled with 2´-O-[(4-CF3-1H-1,2,3-triazol-
1-yl)methyl]uridine (3), and their temperature-dependent behaviour was monitored by 
19F NMR spectroscopy.II In contrast to the above investigated DNA triplexes, these RNA 
triplexes are stable at neutral pH.  
3.4.1 An artificial RNA triplex 
The structure of the artificial RNA triplex is shown in Figure 43. It is a parallel 
pyrimidine motif poly U•A-U triplex construct interrupted by two C+•G-C triplets, and 
the strands are tethered to each other by hexaethylene glycol spacers. It has been 
preciously studied by UV spectroscopy and gel shift mobility assays.288 To monitor both 
triplex and duplex structures, 3 was positioned into the polypyrimidine Watson-Crick 
strand. 
3.4.1.1 UV and CD spectroscopy studies 
The UV melting curve and CD profile of ON13 in comparison of those of the unlabelled 
RNA are shown in Figure 43. The sensor had a marginal effect on the duplex stability, 
and it also only slightly destabilized the triplex. As seen in the CD profiles (Figure 43b), 
the labelling did not induce structural distortions.  
 
Figure 43. (a) UV-melting profile and Tm values of ON13 (blue) in comparison to those of 
unlabelled RNA (black). ΔTm values (in parentheses) in comparison to those obtained with 
unlabelled RNA. (b) CD-profile of ON13 (blue) in comparison to that of unmodified RNA (black) 
at 10 ºC. Conditions: 10 mmol L-1 sodium cacodylate (pH = 7.0), 0.1 mol L-1 NaCl, 2.0 μmol L-1 
of each oligonucleotide. 
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3.4.1.2 19F NMR studies 
The 19F NMR measurements were performed using a mixture of 50 µmol L-1 ON13 in 
0.1 mol L-1 NaCl and 10 mmol L-1 sodium cacodylate at pH 7.0, D2O–H2O (1:9, v/v). As 
can be seen in Figure 44, the thermal denaturation of the intramolecular duplex (H → I) 
could be monitored by the chemical shift changes of the obtained 19F NMR coalescence 
signal (Figure 44a). The melting temperature of the duplex (TmH/I = 59 °C) could be 
extracted from the inflection point of the sigmoidal curve (Figure 44b) after the 
subtraction of the temperature-dependent 19F NMR shift (Figure 44c). The obtained 
melting temperature is in good agreement with the Tm value determined by UV 
spectroscopy (59.3 °C). At a lower temperature (40 °C), a new distinct 19F signal 
appeared (Figure 44a). The relative peak area of this signal increased when the 
temperature was decreased. At 32.5 °C, the signal was of equal size to the duplex-related 
signal. The new signal was assigned to a triplex that denatures at 32.5 °C. However, the 
distinct signals for the duplex and triplex indicated that the equilibrium between these 
structures may be an intermolecular rather than an intramolecular process. The 19F NMR 
measurements were then conducted at a lower ON13 concentration. As seen in 
Figure 44a, the triplex formation was indeed concentration-dependent: at a higher ON13 
concentration (50 µmol L-1), the duplex and triplex signals were of equal size at 32.5 °C 
(= TmG/H), whereas at a lower ON13 concentration (5 µmol L-1), only a trace of the triplex 
signal was detected at the same temperature. Thus, the detected triplex was 
concentration-dependent and may refer to an intermolecular triplex dimer of ON13 (G) 
instead of the expected intramolecular triplex (J). Finally, the molar fractions of the 
triplex (G), duplex (H) and single strand (I) (Figure 44c) were extracted from the relative 
peak areas (G vs H, Figure 44a), and the shift versus temperature profile after the 
subtraction of the passive temperature-dependent shift (H vs I, Figure 44b). 
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Figure 44. (a) 19F NMR spectra of ON13 at different temperatures (5 and 50 µmol L-1 of ON13 
in 0.1 mol L-1 NaCl and 10 mmol L-1 sodium cacodylate at pH 7.0, D2O–H2O (1:9, v/v)). (b) 
19F NMR shift versus temperature profile of ON13 (H vs. I). (c) Molar fractions of the proposed 
dimeric triple helix G, duplex H and single strand I of ON13. The molar fractions of the triplex, 
duplex and single strand were extracted either from the relative peak areas or the shift versus 
temperature profile after the subtraction of the passive temperature-dependent shift. 
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3.4.2 PAN ENE polyA complex 
The PAN ENE structure was identified in a viral transcript produced by an oncogenic 
human gammaherpesvirus, Kaposi’s sarcoma-associated herpesvirus (KSHV).317 During 
the lytic phase (production of infectious virions), KSHV produces a long noncoding 
RNA (lncRNA) polyadenylated nuclear (PAN) RNA.324 The PAN RNA is a 1.1 kb long 
intronless transcript containing a 5´ cap and a 3´ poly(A) tail, and it is the most abundant 
viral transcript during the lytic phase. A 79-nt stem-loop structure, called ENE exists 
near the 3´-end. The ENE contains an asymmetric U-rich internal loop that interacts in 
cis with the poly(A) tail, forming a triple-helical structure (Figure 45).317,324,325 This 
stabilizing interaction protects PAN RNA from a nuclear deadenylation-dependent 
decay pathway and hence enables its accumulation in the nucleus at very high levels. 
Since the characterization of the PAN-ENE polyA complex, ENE-like structures have 
been discovered, for example in other viruses319, plants322, fungi322 and, interestingly, in 
human cancer associated lncRNAs metastasis-associated lung adenocarcinoma 
transcript 1 (MALAT-1)318,320 and multiple endocrine neoplasia-β (MENβ)318.  
 
Figure 45. (a) Schematic presentation of PAN RNA. (b) The predicted secondary structure of the 
PAN ENE complexed with a polyA tail. (c) The schematic presentation of the core ENE model 
complexed with A9 (9 mer adenine oligoribonucleotide) and (d) the crystal structure of this model 
(A9 grey) (PDB ID 3P22317). The uridine residue that was replaced by 3 is circled. (e) U•A-U 
base triplet. 
A 40 mer PAN ENE model bearing the core ENE structure used in previous studies317,318 
was chosen for the 19F NMR investigations (Figure 45). 3 was incorporated into an upper 
stem of the model and in addition, four base pairs at the lower stem were replaced with 
corresponding 2´-O-methyl ribonucleotides (ON14, Figure 46). 
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3.4.2.1 UV and CD spectroscopy studies 
UV-melting studies showed (Table 4) that the 3 had a marginal effect on the stability of 
the PAN ENE hairpin. The Tm values for the PAN ENE A9 complexes, however, could 
not be determined from the melting curves due to the strong background absorbance of 
the hairpin. This is consistent with a previously reported UV study318 in which an unclear 
melting profile was obtained for the complex. According to CD spectroscopy the 
substitution did not induce conformational changes.  
Table 4. UV-melting experiments (Tm/ºC) of the 19F-labelled ON14 
entry oligoribonucleotides hairpin Tm/ºC complex Tm/ºC 
1 ON14 68.8 (-0.2) - 
2 ON14 + A9 68.3 (-0.8) n.d.a 
n.d: absorbance change referring to denaturation of ON14 + A9-complex severely overlapped with 
background absorbance of ON14. Inflection point cannot be determined. ΔTm (in parentheses) in comparison 
to those obtained with unlabelled RNAs. Conditions: 10 mmol L-1 sodium cacodylate (pH = 7.0), 0.1 mol L-1 
NaCl, 2.0 μmol L-1 of each oligonucleotide, UV-detection at 260 nm. 
3.4.2.2 19F NMR studies 
19F NMR measurements were performed using a mixture of 50 µmol L-1 ON14 and 
50 µmol L-1 A9 in 10 mmol L-1 sodium cacodylate buffer (pH 7.0) containing 0.1 mol L-1 
NaCl, D2O–H2O (1:9, v/v). Although the 3 was clearly positioned outside the expected 
binding region of A9, it was able to distinguish the triple helical complex (K) and hairpin 
(L) structures. As seen in Figure 46a, the complex behaved nearly as ON13: a well-
behaving coalescence signal was obtained for the hairpin melting, whereas the 
intermolecular triplex complex gave a distinct signal. The molar fractions of the 
structures and the melting temperatures were extracted from the 19F NMR data (Figure 
46b), as in the case of ON13. The melting temperatures obtained for the triplex (K) and 
the duplex (L) were 20 ºC (TmK/L) and 68 ºC (TmL/M), respectively. As neomycin has been 
shown to stabilize RNA triplexes297, the 19F NMR measurements were additionally 
conducted in the presence of five equivalents of neomycin. The molar ratios of the 
complex (K´), duplex (L´) and single strand (M´) in the presence of neomycin as a 
function of temperature are shown in Figure 46b. As expected, neomycin significantly 
stabilized the triple helical complex (TmK´/L´ = 48 ºC, ∆Tm = 28 ºC) but also did so for the 
hairpin (TmL´/M´ = 83 ºC, ∆Tm = 15 ºC). 
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Figure 46. (a) 19F NMR spectra of ON14 + A9 in different temperatures in the presence and 
absence of neomycin (5 equiv) (50 µmol L-1 ON14 and A9 in 0.1 mol L-1 NaCl and 10 mmol L-1 
sodium cacodylate at pH 7.0, D2O–H2O (1:9, v/v)). (b) Molar fractions of different secondary 
structures at different temperatures (symbols K, L, M and solid lines refer to a mixture without 
neomycin, and symbols K´, L´, M´ and dotted lines to a mixture in the presence of neomycin). 
The molar fractions of the complex, duplex and single strand were extracted either from the 
relative peak areas or the shift versus temperature profile after the subtraction of the passive 
temperature-dependent shift.  
 Results and Discussion 79 
 
3.5 G-quadruplex-hairpin equilibria 
RNA G-quadruplexes formed by guanine-rich RNA sequences have gained considerable 
attention in recent years. RNA G-quadruplexes may be involved in several biological 
processes, such as translation, telomere homeostasis and the processing of 
ncRNAs.193,195,196,198,199,326,327 G-quadruplexes (both RNA and DNA G-quadruplexes) are 
four-stranded nucleic acid structures formed by stacked G-quartets connected by loops 
(Figure 47).192-194 The core unit is a planar G-quartet (tetrad) in which four guanine 
residues are linked together by Hoogsteen hydrogen bonding (Figure 47a). The 
G-quadruplex structures can be intramolecular or intermolecular. The formation and 
stability of G-quadruplexes is dependent on the monovalent cation that is located in the 
central channel of the structure (Figure 47c). In particular, potassium ions strongly 
stabilize G-quadruplexes (K+ > Na+ > Li+). RNA G-quadruplexes prefer a parallel folding 
topology (i.e., all four strands are oriented in the same direction, Figure 47b), which 
simplifies their topological diversity compared to DNA G-quadruplexes. The preference 
for a parallel topology is due to the 2´-hydroxyl groups, which restrict the guanine bases 
to the anti conformation. The antiparallel topology requires a syn conformation, and it is 
hence prevented in RNA. Several other features also contribute to the structural diversity 
and stability of the G-quadruplexes.192-194,328,329 
 
Figure 47. (a) Schematic structure of G-quartet and (b) a parallel tree-quartet G-quadruplex. 
(c) Crystal structure of bimolecular human telomeric RNA G-quadruplex (PDB ID 3IBK242). 
Potassium ions in central channel are shown as black dots, and guanine residues are in light grey 
colour.  
Structural transitions between RNA secondary structures are common in many RNA-
mediated regulatory processes. In some cases, an RNA G-quadruplex structure may be 
in equilibrium with an alternative secondary structure, usually a hairpin.330-341 Such 
intramolecular secondary structural equilibria have recently attracted attention as the 
meanings of RNA G-quadruplexes in biological processes have started to emerge. 
Although few bistable hairpin-G-quadruplex (Hp/Qd) structures have been identified so 
far, the recently published human transcriptome-wide analysis suggested that bistable 
G-quartet
a parallel tree-quartet 
G-quadruplex
a) b) c)
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Hp/Qd structures may be highly relevant structural motifs that play an important role in 
gene regulation.342 Therefore, it might be expected that several Hp/Qd equilibria will be 
identified, as G-quadruplex involving structural switches are a little explored research 
area so far. The Hp/Qd equilibrium is sensitive to the surrounding conditions such as the 
cation content and temperature.330-337 In addition, the equilibrium position may be 
modulated by small molecular ligands330-333,336 and external nucleic acid interactions341. 
Mutations may also affect Hp/Qd transitions.335 Bistable Hp/Qd structures have been 
identified both in non-coding and coding RNAs, and they may affect biologically 
important processes such as pre-miRNA maturation336,337,339, mRNA splicing335 and 
translation332,340. Consequently, it has been proposed that Hp/Qd equilibria may be 
involved in diseases199, and hence they may also be potential novel therapeutic 
targets199,333,334 in addition to RNA G-quadruplexes193,197,199,343. 
The characterization that a G-rich sequence can fold into a G-quadruplex is relatively 
straightforward201 and can be assessed by combining several methods, typically by UV 
melting studies74, CD spectroscopy344 and 1H NMR71,345. Despite the structural 
differences, the quantification of molar fractions in a Hp/Qd equilibrium is complex even 
within short bistable sequences.330-337,339-341,346,347 Among the employed methods, 1H 
NMR spectroscopy has been used to provide direct information of coexisting hairpin and 
G-quadruplex structures.331-333,335,346 The 1H NMR resonances of the imino protons of 
these structures exist in distinct spectral regions. The resonances at 10–12 ppm are 
characteristic of G-quadruplexes (i.e., Hoogsteen base pairing)71,345, whereas the imino-
proton resonances involved in Watson-Crick base pairing may be found at 12–14 ppm66. 
However, the spectral overlap and broadness of the resonance signals interfere with the 
distribution analysis of the conformers.71,331-333,335,345,346 As one of the main advantage of 
19F NMR is that it provides direct quantitative information of coexisting structural 
species and it has been successfully used to investigate several intramolecular hairpin-
hairpin equilibria107,111,142,143, it might be a valuable method to investigate Hp/Qd 
equilibria as well. In the present thesis, a well-characterized artificial Hp/Qd RNA331 
(Figure 48) was chosen for a model system.III In addition, two sequences within prion 
mRNA (Figure 54) that have been previously shown to be Hp/Qd sequences332 were 
chosen to probe the general utility of 19F NMR spectroscopy to characterize such 
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3.5.1 An artificial G-quadruplex-hairpin model 
An artificial Hp/Qd RNA sequence has been constructed by combining a hairpin-
forming sequence derived from a pseudoknot structure of a mouse mammary tumour 
virus and a G-quadruplex-forming sequence from human N-RAS mRNA.331 This 
sequence (with additional 2´-O-methyl modifications) was labelled with purine 
derivatives 5 (ON16) and 6 (ON17).III The synthesized sequences and their schematic 
structures are presented in Figure 48. In addition, 19F-labelled hairpin derivatives with a 
polyU tail (ON19 and ON20) were synthesized as reference structures as well as the 
non-labelled analogues (ON15 and ON18). The influence of the 2´-O-(4-CF3-1H-1,2,3-
triazol-1-yl)methyl reporter group was analysed by UV and CD spectroscopy and the 1H 
NMR analysis of imino protons. 
 
Figure 48. Synthesized sequences and their schematic structures. 
3.5.1.1 UV melting studies  
UV melting studies were performed using a 2 µmol L-1 ON concentration in 0.1 mol L-1 
NaCl, 10 mmol L-1 sodium cacodylate (pH 7.0). The Tm values are listed in Table 5, and 
the corresponding UV melting profiles are shown in Figure 49. At 260 nm, Hp/Qd ONs 
(ON15–17) gave biphasic melting curves. The melting temperatures of the hairpins were 
obtained at the latter inflection points (Figure 49a). The Tm values of reference hairpins 
ON18–20 were comparable with those of the bistable sequences (ON15–17), indicating 
that the nucleobase content of the overhang did not affect the hairpin stability. 
Interestingly, the melting curves of the reference hairpins (ON18–20) were also biphasic 
(Figure 49c). The melting of G-quadruplexes can be followed at 295 nm, and an inverted 
melting profile at this wavelength is a characteristic feature of G-quadruplexes.74 As seen 
in Figure 49b, the bistable sequences ON15–17 gave inverted melting profiles, 
indicating that the sequences were able to adopt G-quadruplex structures. Although the 
19F-labelled RNAs behaved like their non-labelled analogues, the 2´-O-(4-CF3-1H-1,2,3-
triazol-1-yl)methyl reporter group affected the thermal stability of the structures. The 
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reporter group destabilized the hairpin structures (∆TmHp: -3.2 – -6.3 °C), whereas it 
stabilized the G-quadruplex structures (∆TmQd: +2.2 and +4.3 °C). 
Table 5. UV-melting temperatures (Tm/ºC) of the oligoribonucleotides 
entry oligoribonucleotides TmHp/ºC (260 nm) TmQd/ºC (295 nm) 
Hp/Qd RNAs   
1 ON15 74.5 ± 0.0 34.8 ± 0.5
2 ON16 (A) 70.0 ± 0.2 (-4.5) 37.0 ± 0.2 (+2.2) 
3 ON17 (G) 68.2 ± 0.3 (-6.3) 39.1 ± 0.2 (+4.3) 
Hp RNAs 
4 ON18 73.9 ± 0.1 n.a. 
5 ON19 (A) 70.7 ± 0.1 (-3.2) n.a. 
6 ON20 (G) 68.7 ± 0.2 (-5.2) n.a. 
Conditions: 10 mmol L-1 sodium cacodylate (pH = 7.0), 0.1 mol L-1 NaCl, and 2.0 μmol L-1 of each 
oligonucleotide. ΔTm (in parentheses) in comparison to that obtained with an unlabelled model 
(i.e., ON15 or ON18) 
Figure 49. UV-Melting profiles of ON15–20. Conditions same as in Table 5. 
3.5.1.2 CD spectroscopy studies 
The CD spectra of ONs were recorded at 20 °C in a mixture of 10 mmol L-1 sodium 
cacodylate (pH 7.0) and 0.1 mol L-1 mM NaCl. The CD profiles of the Hp RNAs (ON18–
20) displayed characteristic features for an A-form RNA helix76,78, with a strong positive 
peak around 260–270 nm and negative bands at 235 nm and 210 nm (Figure 50b). To 
evaluate the effect of the labelling on G-quadruplex structures, the CD spectra of bistable 
structures were recorded in the presence of KCl, because the K+ ions strongly shift the 
conformational equilibrium toward the G-quadruplex structure. At a 0.1 mol L-1 KCl 
concentration, the CD spectra of ONs 15–17 showed typical features for a parallel 
G-quadruplex344, with a negative peak at 240 nm and a positive peak around 260 nm, but 
ON17 (G-label) additionally showed a negative turn between 210 and 220 nm, which is 
an Hp characteristic feature (Figure 50a). Overall, the labelling has minor effects on the 
secondary structures, except in the case of ON17. In addition, the temperature-dependent 
CD spectra of ON17 (the same mixture as was used for NMR measurements) were 
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recorded and compared with those of the non-labelled analogue (ON15). As seen by 
comparing Figures 50 c and d, the CD profiles of ON17 (50 µmol L-1) were comparable 
to those of ON15 (4 µmol L-1) in 10 mmol L-1 sodium cacodylate (pH 7.0) with 
0.1 mol L-1 NaCl (without KCl). Moreover, the Qd-Hp transition (indicated by arrows in 
the spectra) was observed in both spectra.  
 
Figure 50. CD spectra. (a) and (b) CD spectra of ON15–20 at 20 ºC. Conditions: 2.0-4.0 µmol L-1 
ON in (a) 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, 0.1 mol L-1 KCl and in 
(b) 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, pH 7.0, (c) CD spectra of the NMR sample 
of ON17 (50 µmol L-1) and (d) 4.0 µmol L-1 solution of ON15 at different temperatures in 
10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, pH 7.0.  
3.5.1.3 1H NMR studies 
The recorded imino-proton 1H NMR spectra of ON15–20 are shown in Figure 51 (i-viii). 
The 1H NMR measurements were first performed at a 50 µmol L-1 ON concentration in 
a mixture of 0.1 mol L-1 NaCl and 10 mmol L-1 sodium cacodylate at pH 7.0 
in D2O-H2O (1:9, v/v). As seen (i-iii), the Hp RNAs (ON18–20) gave signals in the range 
12–13 ppm, corresponding to regular Watson-Crick base pairs66. The 2´-O-(4-CF3-1H-
1,2,3-triazol-1-yl)methyl reporter group affected the resonance shifts (marked with 
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asterisks): a downfield shift was observed with the A-label (ON19, ii) and an upfield 
shift with the G-label (ON20, iii), but the intensity of the signals remained unchanged. 
The imino proton resonances of the Hp/Qd RNAs (ONs 15-17, iv-vi) were broad, which 
is consistent with a previously reported study331. In addition to a Watson-Crick 
fingerprint that resembled those of the Hp RNAs (ON18–20), broad resonances were 
detected in the Hoogsteen region (i.e., 10–12 ppm)71,345. Although some changes were 
observed, the reporter group neither caused a significant displacement of the Hp/Qd ratio 
nor induced local decreases in the signal intensity. Additionally, the Hp/Qd equilibrium 
was investigated in the presence of Mg2+ ions (3.0 mmol L-1) that stabilize the Hp-
conformer331. When MgCl2 was added into the samples, the signals broadened, but the 
expected increase in the intensity of the resonances in the Watson-Crick region was 
barely detectable (iv/vii and vi/viii).  
 
Figure 51. 1H NMR- and 19F NMR-spectra of ONs 15–20 at 25°C. 
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3.5.1.4 19F NMR studies 
The 19F NMR spectra (Figure 51 ix-xiv) of ONs 16, 17, 19 and 20 were then recorded. 
Hp RNAs ON19 and ON20 showed sharp signals at -62.63 ppm (A-label, ix) 
and -62.44 ppm (G-label, xi), respectively, whereas two peaks were observed with 
Hp/Qd RNAs ON16 and ON17. ON16 (A-label, x) gave signals at -62.63 ppm 
and -62.94 ppm (broad), and ON17 (G-label, xii) at -62.44 ppm and -62.91 ppm. As in 
both cases the shift of the minor signal corresponded to that of Hp RNAs ON19 and 
ON20, those signals were attributed to Hp-conformers, and hence the major signals 
at -62.94 ppm (A-label) and -62.91 ppm (G-label) could be attributed to Qd-conformers. 
In both cases, the ratio of the peak areas was 0.25:0.75 (Hp/Qd). The effect of the ON 
concentration (5.0 µmol L-1) and Mg2+ ions (3 mmol L-1 MgCl2) on the Hp/Qd 
equilibrium of ON17 was investigated. The distribution of the conformers remained 
unaffected at the lower ON17 concentration (xiii), indicating that the Hp/Qd equilibrium 
is not dependent on the concentration (i.e., an intramolecular process). Compared to 1H 
NMR data (vi/vii), a Mg2+ ion-induced shift to the Hp-conformer was clearly detected: 
the Hp/Qd ratio changed from 0.25:0.75 to 0.54:0.46 (xii/xiv). 
Temperature-dependent measurements 
The temperature-dependent measurements were carried out using 50 µmol L-1 of each 
ON in 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, D2O–H2O (1:9, v/v), pH 7.0. 
The temperature-dependent 19F NMR spectra of Hp/Qd RNAs ON16 and ON17 
(together with those of the Hp RNAs ON19 and ON20) are shown in Figure 52b and 
52d. As seen, the Qd-related 19F-resonances of ON16 and ON17 decreased upon heating, 
and the Hp-related ones increased, existing as a predominant signal upon passing 50 ºC. 
The ratio of the signals (Hp/Qd peak areas) was reproducible, whether the sample was 
heated or cooled (2.5 ºC / 90 min) to the target temperature. As seen in Figure 52c, the 
shifts of the Hp-related resonances of the Hp/Qd RNAs (ON16 and ON17) were in good 
agreement with those of the Hp RNAs (ON19 and ON20) in almost the whole 
temperature range except for temporally incomplete Qd/Hp/Ss coalescence signals at 
52.5–62.5 ºC (ON16) and 57.5–65.0 ºC (ON17). At temperatures over 65 ºC, the 19F 
resonances of ON16 and ON17 followed regular upfield-shifted Hp/Ss-coalescence 
curves. Due to the modest slope of the Hp/Ss-coalescence curves of ON16 and ON19, 
the denaturation range of the Hp-conformer was not easily extracted from the data. In 
contrast, the G-label reflected the melting of the Hp-conformer better, and rather steep 
upfield-shifted Hp/Ss-coalescence curves were observed with ON17 and ON20. A 
minor signal referring to an incomplete Hp/Ss coalescence signal and/or partially 
degraded RNA was observed after the complete denaturation of each RNA (marked with 
asterisks*, fused with the major signal at 80°C). The contribution of this signal (Ss*) 
was taken into account in determining the molar fractions of the Qd/Hp/Ss-transitions. 
The molar fractions of the ON16 and ON17 conformers as functions of temperature are 
shown in Figure 52a. In practice, the ratio of the Qd- and Hp-conformers was extracted 
from the relative peak areas (at 25–70 °C), and that of the Hp- and Ss-conformers (at 
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55–90 °C) from the shift versus temperature profiles. The contribution of the Ss* was 
taken into account by subtracting it from the molar fractions of the conformers, and an 
internal standard was used to confirm the changes in the peak areas. The molar fractions 
of the Qd- and Hp-conformers at temperatures below 50 °C could be determined 
accurately, but due to the modest shift discrimination between the Qd- and Ss-related 
signals (*) the molar fractions of the Qd-conformers at temperatures over 50 °C were 
approximations (the extent of the Ss-related signal * in the overlapped signals was based 
on that observed for Hp RNAs ON19 and ON20).  























Figure 52. Monitoring of the temperature-dependent Qd/Hp-transitions of ON16 and ON17 by 
19F NMR spectroscopy. (a) Molar fractions (x) of the secondary structures: Qd (squares, blue 
lines), Hp (circles, green lines) and Ss (triangles, black lines), ON16 (filled symbols, solid lines) 
and ON17 (open symbols, dotted lines); (b) 19F NMR spectra of ON17 and ON20 
(50 µmol L-1 ON in 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, D2O–H2O (1:9, v/v), 
pH 7.0 at 25–80 °C); (c) 19F NMR resonance shift versus temperature profiles of ON17 (orange 
filled circles, solid line), ON20 (orange open circles, dotted line), ON16 (red filled circles, solid 
line) and ON19 (red open circles, dotted line); (d) 19F NMR spectra of ON16 and ON19 
(50 µmol L-1 ON in 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, D2O–H2O (1:9, v/v), 
pH 7.0 at 25–80°C). 
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To characterize the thermodynamics of the Qd→Hp-transition, the stability constant 
(K = [Qd]/[Hp]) was determined at different temperatures. As seen in Figure 53, lnK 
was linearly dependent on the inverse temperature from 25 to 50 °C whereas severe 
dispersion was observed above 50 °C. Consequently, the thermodynamic parameters for 
the Qd→Hp-transition could be extracted from the linear region. The obtained 
parameters were as follows: ON16: ΔSθ = 116 ± 2 J K-1 mol-1, ΔHθ = 37.3 ± 1.5 kJ K-1 
mol-1, ΔGθ (298.2 K) = 2.7 ± 2.1 kJ K-1 mol-1 and ON17: ΔSθ = 112 ± 5 J K-1 mol-1, 
ΔHθ = 37.1 ± 1.7 kJ K-1 mol-1, ΔGθ (298.2 K) = 3.8 ± 3.3 kJ K-1 mol-1. Importantly, the 
parameters obtained for two different sites of the 2´-O-(4-CF3-1H-1,2,3-triazol-1-
yl)methyl reporter group (ON16 vs ON17) were comparable to each other. The turning 
point of the Qd-Hp transition ([Qd] = [Hp], ΔGθ = 0) was determined from the average 
values and was assigned to be 53 °C. The obtained midpoint transition differs markedly 
from the TmQd values obtained by UV spectroscopy (ON16: 37.0 ± 0.2 ºC and 
ON17: 39.1 ± 0.2 ºC). The UV-based Qd-melting profiles at 295 nm were interfered 
with the denaturation of the Hp-conformers (the increased absorbance > 50°C, Figure 
49b). The obtained UV-values suggested false TmQd values detected from the first 
inflection points (ON16: 32.8 ± 6.7 ºC, ON17: 35.5 ± 1.5 ºC) of the 19F NMR-based 
biphasic melting profiles (Figure 52a). 
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3.5.2 Prion sequences 
Prion diseases, such as Jakob-Creutzfeldt, scrapie, bovine spongiform encephalopathy 
(mad cow disease), are neurodegenerative diseases caused by the conversion of a normal 
cellular prion protein (PrPC) into an infectious misfolded form of the prion protein 
(PrPSc).348,349 The mechanism that initiates this conversion is unknown. Currently, 
nucleic acids are considered one of the potential candidates to induce this 
misfolding.350-352 Interestingly, it has been proposed that the G-quadruplexes might be 
involved in the conversion process352, because G-quadruplex forming aptamers have 
been shown to bind with high affinity to PrPc and to prevent the conversion of PrPc to 
PrPSc 353-357 but also to induce formation of PrPSc by lowering the free energy barrier 
between PrPc and PrPSc 358. Therefore, it has been speculated that PrP’s own mRNA 
might play a role in the conversion process because it contains several consecutive 
guanine stretches.332,352  
Two previously investigated bistable Hp/Qd sequences within prion mRNA332 were 
labelled with 2´-O-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]cytidine (4). In contrast to the 
artificial sequence discussed above that can adopt a tree-quartet G-quadruplex, the 
bistable prion sequences can fold into two-quartet G-quadruplexes that are usually less 
stable than the tree-quartet ones329,359. In addition to 19F-labelled Hp/Qd sequences 
(ON22 and ON24), a 19F-labelled hairpin without an overhang was synthesized as a 
reference structure (ON26) as well as the corresponding non-labelled analogues (ON21, 
ON23 and ON25) (Figure 54). The influence of the 4 was evaluated as above by UV and 
CD spectroscopy and the 1H NMR of imino protons. 
 
Figure 54. The synthesized prion sequences and their schematic structures. 
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3.5.2.1 UV melting studies  
The Tm values are listed in Table 6, and the corresponding UV melting profiles are shown 
in Figure 55. UV melting studies were performed using a 2 µmol L-1 ON concentration 
in 0.1 mol L-1 NaCl, 10 mmol L-1 sodium cacodylate (pH 7.0). Hp/Qd RNAs ON21 and 
ON22 gave biphasic melting curves at 260 nm (Figure 55a), and the melting 
temperatures of the hairpins were obtained at the latter inflection points. The deletion of 
the overhang did not significantly affect the hairpin stability (Hp-RNAs ON25 and 26 
vs Hp/Qd RNAs ON21–24) (Figure 55a, c and d). The melting behaviours of the 
G-quadruplexes were monitored in the presence of K+ ions. Hp/Qd-RNAs I (ON21 and 
ON22) gave inverted melting profiles characteristic of G-quadruplexes74 in the presence 
of 20 mmol L-1 KCl, whereas such profiles were not observed with Hp/Qd-RNAs II 
(ON23 and ON24) even at a higher K+ concentration (0.1 mol L-1) (Figure 55b). 
However, the NMR data revealed G-quadruplex formation with ON23 and ON24, which 
was attributed to the concentration dependency of these G-quadruplexes. The labelled 
RNAs (ON22, ON24, ON26) behaved like their corresponding non-labelled analogues 
(ON21, ON23, ON25), but the label destabilized the hairpin structures 
(∆TmHp = -2.7 – -3.9) and stabilized the G-quadruplex structure (∆TmQd = +3.2 °C). 
Similar effects were observed above with ONs 15–20. 
Table 6. UV-melting temperatures (Tm/ºC) of the oligoribonucleotides 
entry oligoribonucleotides TmHp/ºC (260 nm) TmQd/ºC (295 nm) 
Hp/Qd-RNAs I 
1 ON21 71.5 ± 0.3 55.2 ± 0.7a 
2 ON22 (C) 68.8 ± 0.2 (-2.7) 58.4 ± 0.4 (+3.2)a 
Hp/Qd-RNAs II 
3 ON23 73.0 ± 0.1 n.d. 
4 ON24 (C) 69.1 ± 0.2 (-3.9) n.d. 
Hp-RNAs 
5 ON25 71.7 ± 0.3 n.a. 
6 ON26 (C) 67.9 ± 0.3 (-3.8) n.a. 
Conditions: a2 µmol L-1 ON in 10 mmol L-1 sodium cacodylate (pH = 7.0), 0.1 mol L-1 NaCl, 20 mmol L-1 
KCl, other experiments 10 mmol L-1 sodium cacodylate (pH = 7.0), 0.1 mol L-1 NaCl, and 2.0 μmol L-1 
of each oligonucleotide. ΔTm (in parentheses) in comparison to that obtained with unlabelled model. 
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Figure 55. UV-Melting profiles of ON21–26. Conditions: (a,c,d): 2 µmol L-1 ON21–26 in 
10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, pH 7.0, (b) 2 µmol L-1 ON21 and ON22 in 
10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, 20 mmol L-1 KCl, pH 7.0 and 2 µmol L-1, 
ON23 and ON24 in 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, 0.1 mol L-1 KCl, pH 7.0. 
3.5.2.2 CD spectroscopy studies 
The CD spectra of prion ONs were recorded at 20 °C in a mixture of 10 mmol L-1 sodium 
cacodylate (pH 7.0) and 0.1 mol L-1 NaCl with or without added KCl. The CD profiles 
of the Hp RNAs (ON25 and 26) displayed characteristic features for an A-form RNA 
helix76,78 (Figure 56c). At 20 mmol L-1 KCl the CD spectra of Hp/Qd-RNAs I (ON21 
and ON22) showed Qd-characteristic CD profiles344 (Figure 56a). At 0.1 mol L-1 KCl 
the Hp/Qd RNAs II (ON23 and ON24) displayed Qd-characteristic negative peaks at 
240 nm, but also Hp-characteristic negative values between 210 and 220 nm 
(Figure 56b). Overall, the 4 did not induce significant structural perturbations. The 
temperature-dependent CD spectra of ON22 used for NMR measurements were 
recorded and compared with those of the non-labelled analogue ON21. As seen, the CD 
profiles of ON22 (50 µmol L-1, Figure 56d) were comparable to those of ON21 (4 µmol 
L-1, Figure 56e) in 10 mmol L-1 sodium cacodylate (pH 7.0) with 0.1 mol L-1 NaCl and 
20 mmol L-1 KCl. In contrast to ONs 15 and 17 (Section 3.5.1.2), no clear transitions 
were observed, and Hp/Qd-RNAs I showed Qd-characteristic profiles throughout the 
temperature ramp. 
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Figure 56. (a-c) CD-spectra of ON21–26 at 20ºC. Conditions: 2.0–4.0 µmol L-1 ON in (a) 
10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, 20 mmol L-1 KCl, pH 7.0; (b) 10 mmol L-1 
sodium cacodylate, 0.1 mol L-1 NaCl, 0.1 mol L-1 KCl, pH 7.0 and (c) 10 mmol L-1 sodium 
cacodylate, 0.1 mol L-1 NaCl, pH 7.0. (d) Temperature-dependent CD spectra of the NMR sample 
of ON22 (50 µmol L-1) and (e) 4.0 µmol L-1 solution of ON21 in 10 mmol L-1 sodium cacodylate, 
0.1 mol L-1 NaCl, 20 mmol L-1 KCl, pH 7.0. 
3.5.2.3 1H NMR studies 
As above with ONs 15–20, the effect of the labelling on prion mRNAs models was 
analysed by imino proton 1H NMR spectroscopy. The imino proton 1H NMR spectra are 
shown in Figure 57 (i-x). The 1H NMR measurements were first performed at a 
50 µmol L-1 ON concentration in a mixture of 0.1 mol L-1 NaCl and 10 mmol L-1 sodium 
cacodylate at pH 7.0, D2O–H2O (1:9, v/v) without added KCl (Figure 57 i-vi). As seen, 
a downfield-shifted Watson-Crick signal (marked with asterisks) was observed for the 
labelled sequences, but otherwise the 1H NMR spectra of the labelled RNAs were 
comparable to those of the non-labelled analogues (i/ii, iii/iv, v/vi). Besides the Watson-
Crick resonances, low-intensity resonances were observed in the Hoogsteen region of 
Hp/Qd-RNAs I (ON21 iii and ON22 iv), indicating the presence of Qd-conformers. In 
contrast, Hoogsteen-related resonances were not observed with the Hp/Qd-RNAs II 
(ON23 v and ON24 vi). The imino-proton 1H NMR spectra were then recorded in the 
presence of KCl (Hp/Qd-RNAs I 20 mmol L-1 and Hp/Qd-RNAs II 0.1 mol L-1). As 
expected, the intensity of the Hoogsteen-related resonances increased (ON21 vii and 
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ON22 viii). Hoogsteen-related resonances were also observable for Hp/Qd-RNAs II 
(ON23 ix and ON24 x), showing that these sequences were able to adopt Qd-conformers. 
The obtained 1H NMR data of the Hp/Qd-RNAs II was hence inconsistent with the UV 
melting results, which did not show Qd formation. As the difference between the 
measurements was the concentration (2 µmol L-1 vs 50 µmol L-1), the observed 
Hoogsteen resonances of ON23 and ON24 may be attributed to an intermolecular 
process rather than to an intramolecular Hp/Qd transition.   
 
Figure 57. 1H NMR- and 19F NMR-spectra of ONs 21–26 at 25°C. 
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3.5.2.4 19F NMR studies 
The same samples used in the 1H NMR experiments were used for the 19F NMR 
experiments, and the recorded 19F NMR spectra are shown in Figure 57 (xi-xvii). The 
hairpin (ON26) gave a sharp signal at -62.35 ppm (xi), and this signal was the 
predominant one with both of the Hp/Qd sequences (ON22 xii and ON24 xiii). 
Compared to the 1H NMR spectrum of the ON22, only a trace of the signal related to the 
Qd-conformer was detected in the 19F NMR spectrum (iv/xii). This difference may be 
related to the slow proton exchange of the Hoogsteen hydrogen bonds71. In the presence 
of KCl (ON22 20 mmol L-1 xiv and ON24 0.1 mol L-1 xv), the Qd-conformer was clearly 
detected with both sequences. However, in both cases, a set of Qd-signals were observed 
instead of a single signal, attributed to a mixture of Qd-conformers. To evaluate the 
concentration dependency of the structures, the 19F NMR spectra of the ONs were 
recorded at lower RNA concentrations (5 µmol L-1 versus 50 µmol L-1). As seen, the 
intensity of the Qd-related signals of ON24 decreased (xv/xvii), indicating that 
intermolecular interactions affect the equilibrium. In contrast, the ratio of the conformers 
of ON22 remained unaffected (xiv/xvi).  
The temperature-dependent behaviour of ON22 
The measurements were carried out using 50 µmol L-1 ON22 in 10 mmol L-1 sodium 
cacodylate, 0.1 mol L-1 NaCl, 20 mmol L-1 KCl, D2O–H2O (1:9, v/v), pH 7.0. The molar 
fractions of the structural species (Qd, Hp, Ss) as a function of temperature are shown in 
Figure 58a. Because a set of signals referring to a set of Qds interfered with the 
evaluation of the Hp/Qd ratio, an internal standard (i.e., 5-[4,4,4-trifluoro-3,3-
bis(trifluoromethyl)but-1-ynyl]-2´-deoxyuridine) was used to evaluate the changes in the 
peak areas [molar fractions: x(Qd) = 1 – x(Hp + Ss), x(Hp + Ss) = A(Hp + Ss)/Atot 
compared to an standard]. The molar fractions of Hp and Ss were extracted from the 
shift versus temperature profile. The Hp-conformer of ON22 did not accumulate as in 
the case of artificial ONs 16 and 17. The Qd/Hp ratio remained almost unchanged 
throughout the temperature ramp, and the melting temperatures (Tm(Qd) = 70.3 ± 1.1 °C 
and Tm(Hp) = 72.7 ± 0.5 °C) of the conformers were close to each other. The obtained 
Tm value for the Qd-conformer was much higher than that determined by UV 
spectroscopy (58.4 °C). As seen in Figure 58b, changes in the peak set referring to Qd-
conformers were observed upon heating. In addition, the equilibration rate of the Qd/Hp–
ratio of ON22 was questionably slow (despite the Qd/Hp-ratio being reproducible 
whether the sample was heated or cooled to the target temperature). Taken together, it 
may be concluded that intermolecular Hoogsteen interactions disturbed the Qd/Hp ratio 
in the concentration used for the 19F NMR analysis (50 µmol L-1 of ON22), although the 
intramolecular Qd/Hp transition may take place at a lower concentration332.  
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Figure 58.  Monitoring of the temperature-dependent Qd/Hp-transition of ON22 by 19F NMR 
spectroscopy. (a) Molar fractions (x) of the secondary structures: Qd (squares, blue line), Hp 
(circles, green line) and Ss (triangles, black line); (b) 19F NMR spectra of ON22 (50 µmol L-1 
ON22 in 10 mmol L-1 sodium cacodylate, 0.1 mol L-1 NaCl, 20 mmol L-1 KCl, D2O–H2O 
(1:9, v/v), pH 7.0 at 25–90°C. 
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4. CONCLUSIONS 
Six novel fluorine-labelled building blocks were synthesized, and their applicability as 
fluorine sensors was evaluated. Phosphoramidite building blocks of 4´-C-[(4-CF3-1H-
1,2,3-triazol-1-yl)methyl]thymidine (12) and 2´-O-[(4-CF3-1H-1,2,3-triazol-1-
yl)methyl]uridine (29a), -cytidine (29b), -adenosine (29c), guanosine (29d) were 
obtained in relatively high yields. The (4-CF3-1H-1,2,3-triazol-1-yl)methyl reporter 
group was easily accessible in each case. Importantly, the 2´-O-(4-CF3-1H-1,2,3-triazol-
1-yl)methyl group could be introduced to all four common ribonucleosides, enabling 
incorporation at any position in RNAs. In contrast, the phosphoramidite building block 
of 4´-C-[4-(trifluoromethyl)phenyl]uridine (22) was obtained with a low yield after a 
multistep synthesis. All the phosphoramidite building blocks were stable under solid-
phase synthesis and cleavage conditions, and no special adjustments were required for 
conventional synthesis procedures. Phosphoramidite building blocks 12 and 29a-d were 
coupled efficiently, either manually or as an integral part of oligonucleotide synthesis, 
whereas a lower coupling efficiency was obtained with 22.  
The 19F NMR spectroscopic experiments showed that the reporter groups provided sharp 
19F signals as singlets without proton decoupling techniques. However, in addition to the 
synthetic shortcomings, a modest discrimination between single- and double-stranded 
environments was observed with 4´-C-[4-(trifluoromethyl)phenyl]uridine (2), and it was 
not used to characterize secondary structures. 
The applicability of 4´-C-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]thymidine (1) was 
demonstrated in both DNA and RNA environments. It was proven to be a relatively non-
perturbing substitution in both environments. It was able to reflect DNA triplex 
structures when bound to either a Watson-Crick or a Hoogsteen face. The molar fractions 
of the triplex/duplex/single strand were obtained from well-separated 19F signals, and Tm 
values were obtained from temperature-dependent 19F NMR data. In addition, a 
previously conducted RNA invasion study was repeated, and the temperature-dependent 
behaviour of the invasion complex was successfully monitored.  
2´-O-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]uridine (3) was applied to investigate the 
temperature-dependent behaviour of RNA triplexes, and the applicability of 19F NMR 
spectroscopy to investigate RNA triplexes was demonstrated for the first time. 3 was 
proven to be a non-invasive analogue readily reflecting triplex, duplex and single strand 
environments, and the molar fractions of the structural specifies were easily determined. 
In addition to the Tm values, the concentration dependency of the artificial triplex model 
was revealed. Significantly, the temperature-dependent behaviour of a PAN ENE polyA 
complex was characterized, and Tm values for the triplex complex and hairpin were 
obtained in the absence and presence of neomycin.  
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2´-O-[(4-CF3-1H-1,2,3-triazol-1-yl)methyl]cytidine (4), -adenosine (5) and -guanosine 
(6) were used to characterize RNA G-quadruplex/hairpin transitions. The molar fractions 
of the Hp- and Qd-conformers were determined under different temperatures and ionic 
conditions. 4–6 were also able to reflect the concentration dependency of the Qd-
conformation, i.e., the formation of intra- and intermolecular Qd species. In addition, Tm 
values and thermodynamic parameters were extracted from the temperature-dependent 
19F NMR data. Although no significant structural perturbations were observed, except in 
the case of 6-modified Qd-conformer, the analogues affected the stability of both 
conformers and hence the molar ratios of the conformers, and these effects need to be 
taken in account when directly compared to the native Hp/Qd equilibria. Whether the 
observed stability effects are general properties of the derivatives or may be overcome 
by labelling position changes needs to be assessed with further studies. Nevertheless, 
compared to UV and CD spectroscopy as well as 1H NMR, the simplicity of determining 
the ratio of the conformers directly from 19F signals in a variety of conditions was 
demonstrated, and bistable Hp-Qd RNA models were analysed by 19F NMR 
spectroscopy for the first time. 
In summary, due to the efficient synthesis of 12 and 29a-d, their facile incorporation into 
oligonucleotides and the beneficial 19F NMR spectroscopic properties, 1 and 3-6 may be 
considered potential analogues for further 19F NMR studies. 
The potential of 19F NMR spectroscopy to investigate nucleic acids has been 
demonstrated with several studies, but also the common limitations of this method and 
the importance of the development of novel 19F-modified analogues for further 
applications have been recognized. In general, the choice of the appropriate 
19F-modification for the given application depends on the nucleic acid of interest and the 
primary experimental goal. In addition to 19F NMR spectroscopy, a variety of other 
methods are also available to investigate nucleic acids, such as NMR spectroscopy with 
other nuclei (1H, 15N, 13C) and spectrophotometric methods, each with its strengths and 
limitations. NMR spectroscopy is in general invaluable tool to investigate nucleic acids. 
Commonly, spin-labels and multidimensional NMR methods are needed to overcome 
the reduced chemical shift dispersion of protons.66-72 One of the advantage of 19F NMR 
spectroscopy is the simplicity and informational richness of the 1D 19F NMR spectra, 
and therefore the utility of 19F NMR spectroscopy do not require NMR specialization in 
the same extent that is needed for studying complex nucleic acid structures or structural 
equilibria by 1H NMR spectroscopy. Spectrophotometric methods, such as UV73-75 and 
CD spectroscopy76-78 as well as fluorescence based methods79,80, are inherently more 
sensitive methods than NMR spectroscopy. Fluorescence based methods are extensively 
used to investigate nucleic acids and a vast amount of applications have been 
described.79,80 Because nucleic acids are inherently non-fluorescent, it is necessary to 
introduce a fluorescent modification into a nucleic acid, and currently, a number of 
fluorescent analogues are available. In principle, fluorescence based methods and 19F 
NMR spectroscopy share some common general aspects, because prerequisite for both 
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of these techniques is the incorporation of an unnatural modification into a target nucleic
acid (or its ligand). For instance, challenges in development and synthesis of appropriate
building blocks and introducing them efficiently into oligonucleotides can limit the
utility of these techniques. In addition, the introduced modification can affect
significantly on nucleic acid structure and/or stability. In general, the utility of a labelled
building block depends not only its general properties, but also its behaviour in particular
structure and its ability to reflect the process of interest. UV73-75 and CD76-78 studies are
also commonly used to investigate nucleic acids. These methods do not require labelling
of the nucleic acid of interest, but analysing intermediate structures, coexisting structural
species or large nucleic acids is often difficult with these methods. In particular, the
strength of 19F NMR is that it provides direct quantitative information of coexisting
structural species and it can be readily used to analyse changes in structural equilibria
induced by environmental changes, such as ions, temperature and pH, or interaction
partners, such as small molecules, nucleic acids and proteins. This valuable characteristic
feature of 19F NMR was also demonstrated in this thesis by investigating DNA and RNA
triplexes, RNA invasion process and RNA G-quadruplex-hairpin equilibria with novel
fluorine-labelled nucleoside analogues 1 and 3-6.
 




The synthesis and characterization of the compounds are described in the original 
publications. The synthesized novel compounds were characterized by 1H NMR, 13C 
NMR, 31P NMR 19F NMR and MS when applicable.  
Synthesis of 20 by 5´-debenzoylation strategy 
The bottleneck of the synthesis of 22 was the tritylation step and the alternative synthetic 
routes are shortly summarized here. However, as stated in Section 3.1.1.1 the direct 
tritylation of 19 was practically straightforward approach, and importantly, the bis- and 
monotritylated sideproducts were readily converted back to the starting material by 
dicloroacetic acid treatment. The selective removal of the 5´-O-Bz protection was most 
successful with [tBuSnOHCl]2261,360 (Scheme 4). However, it has been reported that the 
selective 5´-debenzoylation with this tin catalyst is sensitive to the amount of catalyst, 
reaction time and temperature, and reaction can provide a complex mixture of 
products.261 This was also the case with 18 and several test reactions were conducted 
varying the amount of catalyst, reaction time and temperature to obtain 33 in a moderate 
yield (61 %). The best result was obtained in dry MeOH with 30 mol% of catalyst at 66 
°C for 68 h, but the obtained mixture of compounds complicated the purification. 
Tritylation of 33 with excess of DMTrCl for 120 h gave 34 in an 84% yield (yield from 
18 51%). 
 
Scheme 4. (i) [tBuSnOHCl]2, MeOH; (ii) DMTrCl, Py; (iii) NaOMe, MeOH. 
Although NaOMe is unspesific reagent for selective debenzoylation, it was also tested 
for cleaving 5´-O-Bz group selectively. 33 was noticed to accumulate in some extent 
during debenzoylation reaction. Treatment of 18 with 0.1 ekv of NaOMe solution for 
10-30 min provided a mixture of products, as expected. The obtained crude was then 
tritylated and 34 was obtained in 48% yield. Although the yield is comparable to that of 
the tin method, the NaOMe step was hard to control. 5´-Debenzoylation was also tested 
using 1 % iodine-methanol solution361, but this attempt was unsuccessful.  
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Synthesis of 2´-O-TBDMS-protected 4´-C-[4-(trifluoromethyl)phenyl]uridine 
phosphoramidite 
Synthesis of 2´-O-TBDMS-protected 4´-C-[4-(trifluoromethyl)phenyl]uridine 
phosphoramidite (36) from 20 is depicted in Scheme 5. First 2´-OH group was silylated 
with TBDMSCl in the presence of AgNO3362 (35 in 33% yield). The reaction proceeded 
slowly and a mixture of products was obtained. 35 was then phosphitylated, and also this 
reaction was difficult due to the steric hindrance of 4´-C-[4-(trifluoromethyl)phenyl] and 
2´-O-TBDMS groups. High excess of 2-cyanoethyl N,N-diisopropylchloro-
phosphoramidite (6 ekv) and prolonged reaction time at elevated temperature (48 h at 
55°C) were required to obtain 36 in 38% yield. This building block coupled inefficiently 
due to the bulky TBDMS group. The coupling efficiency improved significantly, from 
20 to 90%, when the 2´-OH group was protected with sterically less demanding TOM 
group (22, Section 3.1.2). In addition, the phosphitylation reaction was easier with TOM-
protected compound (Scheme 2). Smaller excess of 2-cyanoethyl 
N,N-diisopropylchlorophosphoramidite (3.5 ekv) could be used and the reaction 
proceeded at ambient temperature (24 h) in  a good yield (22, 86%).  
 
Scheme 5. (i) TBDMSCl, Py, AgNO3, THF; (ii) 2-cyanoethyl N,N-diisopropylchloro-
phosphoramidite, Et3N, DCM. 
5.2 Oligonucleotide synthesis 
The detailed synthetic methods of the oligonucleotides are described in the original 
publications. Oligonucleotides were synthesized on an Applied Biosystems 3400 
DNA/RNA synthesizer using standard protocols. The manual coupling of 
phosphoramidites 12, 22 and 29d is described in Section 3.2.1. The oligonucleotides 
were released from the support by standard ammonolysis (oligonucleotides in 
concentrated ammonia at 55 ºC overnight, oligoribonucleotides in a mixture of 
concentrated ammonia and ethanol 3:1, v/v, 3.5 h at 55 ºC and overnight at rt). The silyl 
protections were removed by a mixture of triethylamine trihydrofluoride (75 μL), 
triethylamine (60 μL) and DMSO (115 μL) (for 2.5 hours at 65 ºC). Then, 0.1 mol L-1 
NaOAc (10 mL) was added to the mixture, and it was loaded into a cartridge (Poly Pak 
II, Glen Research). 0.1 mol L-1 aqueous triethylammonium acetate (6.0 mL, pH = 7.0) 
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was eluted though the cartridges to remove traces of reagents and protecting groups. The 
crude oligoribonucleotides were released by elution with 60 % aqueous acetonitrile. 
Oligonucleotides were purified with RP-HPLC using a semipreparative column, a 
Phenomenex Oligo-RP C18 (250×10mm, 5 µm), with a gradient elution, typically from 
0 to 40-60 % acetonitrile in 0.1 mol L-1 aqueous triethylammonium acetate in 25 min at 
ambient or elevated temperature, flow rate 3.0 ml min-1, and UV detection at 260 nm. 
The homogeneity of the purified oligonucleotides was analysed by an analytical RP 
HPLC column, a Thermo ODS Hypercil C18 (250 × 5 mm, 5µm), flow rate 1.0 ml min-1, 
detection at 260 nm, and elution conditions the same as those of the semipreparative 
column. The authenticity of the oligonucleotides was verified by ESI-TOF MS.  
5.3 UV melting studies and CD spectroscopy experiments 
The detailed measurement conditions for the UV melting temperature and CD 
spectroscopy studies are described in the Results and Discussion section and in the 
original publications. The melting curves (absorbance versus temperature) were 
measured at 260 nm or 295 nm on a Perkin-Elmer Lambda 35 UV-vis spectrometer 
equipped with a multiple cell holder and a Peltier temperature controller. Tm values were 
determined as the maximum of the first derivative of the melting curve. The CD spectra 
were measured using an Applied Photophysics Chirascan spectropolarimeter. For both 
equipment, an internal thermometer was additionally used to verify the validity of the 
target temperature.  
5.4 19F NMR and 1H NMR experiments of the oligonucleotides 
The detailed measurement conditions for 1H NMR and 19F NMR measurements are 
described in the Results and Discussion section and in the original publications. 19F NMR 
spectra were recorded at a frequency of 470.6 MHz on a Bruker Avance 500 MHz 
spectrophotometer. Typical experimental parameters were as follows: 19F excitation 
pulse 4.0 μs, acquisition time 1.17 s, prescan delay 6.0 μs, relaxation delay 0.8 s and 
usual numbers of scans (ns) 1024, 2048 and 20480. The parameters were optimized to 
obtain the signals with the longest relaxation rate. A macro command was used for the 
automatic temperature ramps using a 20 min equilibration time for each temperature. 
The sample temperatures were calibrated using known shifts of ethylene glycol at 
different temperatures. The 1H NMR spectra of the imino regions at 25°C were recorded 
at a frequency of 500.1 MHz on a Bruker Avance 500 MHz spectrophotometer. Water 
was suppressed by an excitation sculpting technique.  
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